Updated on 2025/04/30

写真a

 
Takuya Takahashi
 
Organization
Graduate School of Medicine Department of Medicine Physiology Professor
School of Medicine Medical Course
Title
Professor
Profile

シナプス可塑性の分子メカニズムとしてAMPA受容体シナプス移行の研究を行っている。この基礎研究を元にリハビリテーション効果促進薬の開発、AMPA受容体標識PET Probeの開発を行っている。基礎研究の強固な根拠の基づく精神神経疾患の革新的診断治療法確立を目指す。
〔研究履歴〕
2006年 横浜市立大学大学院医学研究科教授
2001年-2005年 Cold Spring Harbor 研究所Postdoctoral fellow
(Roberto Malinow博士)
1995年-2000年 Yale大学大学院博士課程 (Stephen M. Strittmatter博士)

〔学歴〕
2000年 Yale大学大学院博士課程 修了
1995年 慶應義塾大学医学部 卒業

 

科研費:https://nrid.nii.ac.jp/ja/nrid/1000020423824/

 

External link

Degree

  • 医学博士 ( Yale University )

Research Interests

  • 脳プロ

  • AMPA受容体

  • 経験依存的

  • バレル皮質

  • 包括脳ネットワーク

  • シナプス

  • 可塑性

  • 社会的隔離

  • アンタゴニスト

  • ストレスホルモン

Research Areas

  • Life Science / Neuroscience-general

Research History

  • 国立大学法人東京大学国際高等研究所   ニューロインテリジェンス国際研究機構   連携研究員(兼務)

    2021.10

      More details

  • 横浜市立大学 医学(系)研究科(研究院)   教授

    2009

      More details

  • 横浜市立大学 医学部   教授

    2007 - 2008

      More details

  • 横浜市立大学 医学研究科   教授

    2006 - 2007

      More details

  • Yokohama City University

    2006

      More details

Professional Memberships

▼display all

Papers

  • α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality

    Taisuke Yatomi, Dardo Tomasi, Hideaki Tani, Shinichiro Nakajima, Sakiko Tsugawa, Nobuhiro Nagai, Teruki Koizumi, Waki Nakajima, Mai Hatano, Hiroyuki Uchida, Takuya Takahashi

    Frontiers in Neural Circuits   18   2024.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Local and global functional connectivity densities (lFCD and gFCD, respectively), derived from functional magnetic resonance imaging (fMRI) data, represent the degree of functional centrality within local and global brain networks. While these methods are well-established for mapping brain connectivity, the molecular and synaptic foundations of these connectivity patterns remain unclear. Glutamate, the principal excitatory neurotransmitter in the brain, plays a key role in these processes. Among its receptors, the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is crucial for neurotransmission, particularly in cognitive functions such as learning and memory. This study aimed to examine the association of the AMPAR density and FCD metrics of intraregional and interregional functional centrality. Using [<sup>11</sup>C]K-2, a positron emission tomography (PET) tracer specific for AMPARs, we measured AMPAR density in the brains of 35 healthy participants. Our findings revealed a strong positive correlation between AMPAR density and both lFCD and gFCD-lFCD across the entire brain. This correlation was especially notable in key regions such as the anterior cingulate cortex, posterior cingulate cortex, pre-subgenual frontal cortex, Default Mode Network, and Visual Network. These results highlight that postsynaptic AMPARs significantly contribute to both local and global functional connectivity in the brain, particularly in network hub regions. This study provides valuable insights into the molecular and synaptic underpinnings of brain functional connectomes.

    DOI: 10.3389/fncir.2024.1497897

    researchmap

  • Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography

    Mai Hatano, Waki Nakajima, Hideaki Tani, Hiroyuki Uchida, Tomoyuki Miyazaki, Tetsu Arisawa, Yuuki Takada, Sakiko Tsugawa, Akane Sano, Kotaro Nakano, Tsuyoshi Eiro, Hiroki Abe, Akira Suda, Takeshi Asami, Akitoyo Hishimoto, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Shunya Kurokawa, Yohei Ohtani, Kie Takahashi, Yuhei Kikuchi, Taisuke Yatomi, Shiori Honda, Masahiro Jinzaki, Yoji Hirano, Ryo Mitoma, Shunsuke Tamura, Shingo Baba, Osamu Togao, Hirotaka Kosaka, Hidehiko Okazawa, Yuichi Kimura, Masaru Mimura, Takuya Takahashi

    Molecular Psychiatry   2024.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Synaptic phenotypes in living patients with psychiatric disorders are poorly characterized. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a fundamental component for neurotransmission. We recently developed a positron emission tomography (PET) tracer for AMPAR, [<sup>11</sup>C]K-2, the first technology to visualize and quantify AMPARs density in living human brain. In this study, we characterized patients with major psychiatric disorders with [<sup>11</sup>C]K-2. One hundred forty-nine patients with psychiatric disorders (schizophrenia, n = 42; bipolar disorder, n = 37; depression, n = 35; and autism spectrum disorder, n = 35) and 70 healthy participants underwent a PET scan with [<sup>11</sup>C]K-2 for measurement of AMPAR density. We detected brain regions that showed correlation between AMPAR density and symptomatology scores in each of four disorders. We also found brain areas with significant differences in AMPAR density between patients with each psychiatric disorder and healthy participants. Some of these areas were observed across diseases, indicating that these are commonly affected areas throughout psychiatric disorders. Schizophrenia, bipolar disorder, depression, and autism spectrum disorder are uniquely characterized by AMPAR distribution patterns. Our approach to psychiatric disorders using [<sup>11</sup>C]K-2 can elucidate the biological mechanisms across diseases and pave the way to develop novel diagnostics and therapeutics based on the synapse physiology.

    DOI: 10.1038/s41380-024-02785-1

    researchmap

    Other Link: https://www.nature.com/articles/s41380-024-02785-1

  • Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial. International journal

    Yohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, Taisuke Yatomi, Kengo Yonezawa, Sota Tomiyama, Nobuhiro Nagai, Keisuke Kusudo, Shiori Honda, Sotaro Moriyama, Shinichiro Nakajima, Takashige Yamada, Hiroshi Morisaki, Yu Iwabuchi, Masahiro Jinzaki, Kimio Yoshimura, Tsuyoshi Eiro, Sakiko Tsugawa, Sadamitsu Ichijo, Yu Fujimoto, Tomoyuki Miyazaki, Takuya Takahashi, Hiroyuki Uchida

    Psychiatry and clinical neurosciences   2024.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: Although the antidepressant effect of ketamine on treatment-resistant depression (TRD) has been frequently reported in North American and European countries, evidence is scarce among the Asian population. We aimed to evaluate the efficacy and safety of intravenous ketamine in Japanese patients with TRD. METHODS: In this double-blind randomized placebo-controlled trial, 34 Japanese patients with TRD were randomized to receive either intravenous ketamine (0.5 mg/kg) or placebo, administered over 40 min, twice a week, for 2 weeks. The primary outcome was the change in the Montgomery Åsberg Depression Rating Scale (MADRS) total score from baseline to post-treatment. Secondary outcomes included changes in other depressive symptomatology scores and remission, response, and partial response rates. We also examined the association between baseline clinical demographic characteristics and changes in the MADRS total score. RESULTS: Intention-to-treat analysis indicated no significant difference in the decrease in MADRS total score between the groups (-8.1 ± 10.0 vs -2.5 ± 5.2, t[32] = 2.02, P = 0.052), whereas per-protocol analysis showed a significant reduction in the ketamine group compared to the placebo group (-9.1 ± 10.2 vs -2.7 ± 5.3, t[29] = 2.22, P = 0.034). No significant group differences were observed in other outcomes. Adverse events were more frequent in the ketamine group than in the placebo group, and no serious adverse events were reported. A higher baseline MADRS total score and body mass index were associated with a greater reduction in the MADRS total score. CONCLUSION: Intravenous ketamine outperformed placebo in Japanese patients with TRD who completed the study, suggesting that ketamine could alleviate depressive symptoms of TRD across diverse ethnic populations.

    DOI: 10.1111/pcn.13734

    PubMed

    researchmap

  • Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertension. International journal

    Mari Sotozawa, Sho Kinguchi, Hiromichi Wakui, Kengo Azushima, Kengo Funakoshi, Waki Nakajima, Tomoyuki Miyazaki, Takuya Takahashi, Kouichi Tamura

    Hypertension research : official journal of the Japanese Society of Hypertension   47 ( 1 )   67 - 77   2024.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The renin-angiotensin system in the brain plays a pivotal role in modulating sympathetic nerve activity and contributes to the pathogenesis of hypertension. Angiotensin II (Ang II) type 1 receptor (AT1R)-associated protein (ATRAP) promotes internalization of AT1R while suppressing pathological overactivation of AT1R signaling. However, the pathophysiological function of ATRAP in the brain remains unknown. Therefore, this study aims to investigate whether ATRAP in the paraventricular nucleus (PVN) is involved in neurogenic hypertension pathogenesis in Ang II-infused rats. The ATRAP/AT1R ratio, which serves as an indicator of tissue AT1R hyperactivity, tended to decrease within the PVN in the Ang II group than in the vehicle group. This suggests an Ang II-induced hyperactivation of the AT1R signaling pathway in the PVN. Lentiviral vectors were generated to stimulate ATRAP expression. At 6 weeks of age, rats were microinjected with LV-Venus (Venus-expressing lentivirus) or LV-ATRAP (Venus-ATRAP-expressing lentivirus). The rats were then randomly divided into four groups: (1) Vehicle/LV-Venus, (2) Vehicle/LV-ATRAP, (3) Ang II/LV-Venus, and (4) Ang II/LV-ATRAP. Two weeks after microinjection, vehicle or Ang II was administered systemically for 2 weeks. In the Ang II/LV-ATRAP group, systolic blood pressure at 1 and 2 weeks following administration was significantly lower than that in the Ang II/LV-Venus group. Furthermore, urinary adrenaline levels tended to decrease in the Ang II/LV-ATRAP group than in the Ang II/LV-Venus group. These findings suggest that enhanced ATRAP expression in the PVN suppresses Ang II-induced hypertension, potentially by suppressing hyperactivation of the tissue AT1R signaling pathway and, subsequently, sympathetic nerve activity.

    DOI: 10.1038/s41440-023-01480-y

    PubMed

    researchmap

  • AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines. International journal

    Nami Masumoto, Shingo Kato, Masahiro Aichi, Sho Hasegawa, Kota Sahara, Kumiko Suyama, Akane Sano, Tomoyuki Miyazaki, Koji Okudela, Takeshi Kaneko, Takuya Takahashi

    Thoracic cancer   14 ( 29 )   2897 - 2908   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Small cell lung cancer (SCLC) is a neuroendocrine tumor with poor prognosis. Neuroendocrine tumors possess characteristics of both nerve cells and hormone-secreting cells; therefore, targeting the neuronal properties of these tumors may lead to the development of new therapeutic options. Among the endogenous signaling pathways in the nervous system, targeting the glutamate pathway may be a useful strategy for glioblastoma treatment. Perampanel, an antagonist of the synaptic glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR), has been reported to be effective in patients with glioblastoma. In this study, we aimed to investigate the antitumor effects of AMPAR antagonists in human SCLC cell lines. METHODS: We performed to examine the expression of AMPAR using Western blot and immunohistochemical analysis. The antitumor effects of AMPAR antagonists on human SCLC cell lines were investigated in vitro and in vivo. We also analyzed the signaling pathway of AMPAR antagonists in SCLC cell lines. Statistical analysis was performed by the GraphPad Prism 6 software. RESULTS: We first examined the expression of endogenous AMPAR in six human SCLC cell lines, detecting AMPAR proteins in all of them. Next, we tested the anti-proliferative effect of two AMPAR antagonists, talampanel and cyanquixaline, using SCLC cells in vitro and in vivo. Both AMPAR antagonists inhibited cell proliferation and mitogen-activated protein kinase (MAPK) phosphorylation in SCLC cells in vitro. Further, we observed reduced proliferation of implanted cell lines in an in vivo setting, assessed by Ki-67 immunohistochemistry. Additionally, using immunohistochemical analysis we confirmed AMPAR protein expression in human SCLC samples. CONCLUSION: AMPAR may be a potential therapeutic target for SCLC.

    DOI: 10.1111/1759-7714.15075

    PubMed

    researchmap

  • Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy. Reviewed International journal

    Tsuyoshi Eiro, Tomoyuki Miyazaki, Mai Hatano, Waki Nakajima, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Akane Sano, Kotaro Nakano, Takahiro Mihara, Yutaro Takayama, Naoki Ikegaya, Masaki Iwasaki, Akitoyo Hishimoto, Yoshihiro Noda, Takahiro Miyazaki, Hiroyuki Uchida, Hideaki Tani, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Masaru Mimura, Nozomu Matsuda, Kazuaki Kanai, Kazuhiro Takahashi, Hiroshi Ito, Yoji Hirano, Yuichi Kimura, Riki Matsumoto, Akio Ikeda, Takuya Takahashi

    Cell reports. Medicine   4 ( 5 )   101020 - 101020   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) contribute to epileptogenesis. Thirty patients with epilepsy and 31 healthy controls are scanned using positron emission tomography with our recently developed radiotracer for AMPARs, [11C]K-2, which measures the density of cell-surface AMPARs. In patients with focal-onset seizures, an increase in AMPAR trafficking augments the amplitude of abnormal gamma activity detected by electroencephalography. In contrast, patients with generalized-onset seizures exhibit a decrease in AMPARs coupled with increased amplitude of abnormal gamma activity. Patients with epilepsy had reduced AMPAR levels compared with healthy controls, and AMPARs are reduced in larger areas of the cortex in patients with generalized-onset seizures compared with those with focal-onset seizures. Thus, epileptic brain function can be regulated by the enhanced trafficking of AMPAR due to Hebbian plasticity with increased simultaneous neuronal firing and compensational downregulation of cell-surface AMPARs by the synaptic scaling.

    DOI: 10.1016/j.xcrm.2023.101020

    PubMed

    researchmap

  • Synthesis of [F-18] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors Reviewed

    Tetsu Arisawa, Kimito Kimura, Tomoyuki Miyazaki, Yuuki Takada, Waki Nakajima, Wataru Ota, Sadamitsu Ichijo, Akane Sano, Yuuka Hirao, Jun-ichi Kurita, Yoshifumi Nishimura, Takuya Takahashi

    NUCLEAR MEDICINE AND BIOLOGY   110   47 - 58   2022.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Introduction: AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) receptors play a central role in neurotransmission and neuronal function. A positron emission tomography (PET) tracer for AMPA re-ceptors, [C-11]K-2, was recently developed by us to visualize AMPA receptors in the living human brain. [C-11]K-2 is a derivative of 4-[2-(phenylsulphonylamino)ethylthio]-2,6-difuluoro-phenoxyacetamide (PEPA), and is labeled with the radioactive isotope C-11, which has a short half-life. PET drugs are usually labeled with F-18 because of its long half-life. Therefore, we screened and identified potential F-18-labeled PET drugs for AMPA receptors (AMPA-PET drugs), which could provide an image equivalent to that of [C-11]K-2. Methods: Derivatives of K-2 labeled with F-18 were synthesized and administered to rats and PET imaging was performed. The transferability of each compound to the brain and its correlation with the PET image of [C-11]K-2 were evaluated from the obtained PET images. Furthermore, the specific binding ability of promising compounds to the AMPA receptor was evaluated by the PET imaging of rats, which we specifically knocked down the expression of AMPA by the lentivirus-mediated introduction of short hairpin RNA (shRNA) targeted to subunits of the AMPA receptor (GluA1-A3). The specific binding ability was also evaluated through electrophysiological experiments with acute brain slices. Results: Some of the synthesized F-18-labeled candidate compounds showed a distribution similar to that of K-2, with reasonable transferability to the brain. In addition, from the evaluation of the specific binding ability to the AMPA receptor, a promising structure of an 18F-labeled AMPA PET drug was identified. This study also revealed that the alkylation of the sulfonamide group of PEPA enhances brain transferability.

    DOI: 10.1016/j.nucmedbio.2022.04.009

    Web of Science

    researchmap

  • Epileptic discharges initiate from brain areas with elevated accumulation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors. Reviewed International journal

    Tomoyuki Miyazaki, Yutaro Takayama, Masaki Iwasaki, Mai Hatano, Waki Nakajima, Naoki Ikegaya, Tetsuya Yamamoto, Shohei Tsuchimoto, Hiroki Kato, Takuya Takahashi

    Brain communications   4 ( 2 )   fcac023   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Presurgical identification of the epileptogenic zone is a critical determinant of seizure control following surgical resection in epilepsy. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor is a major component of neurotransmission. Although elevated α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor levels are observed in surgically resected brain areas of patients with epilepsy, it remains unclear whether increased α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor-mediated currents initiate epileptic discharges. We have recently developed the first PET tracer for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, [11C]K-2, to visualize and quantify the density of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors in living human brains. Here, we detected elevated [11C]K-2 uptake in the epileptogenic temporal lobe of patients with mesial temporal lobe epilepsy. Brain areas with high [11C]K-2 uptake are closely colocalized with the location of equivalent current dipoles estimated by magnetoencephalography or with seizure onset zones detected by intracranial electroencephalogram. These results suggest that epileptic discharges initiate from brain areas with increased α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, providing a biological basis for epileptic discharges and an additional non-invasive option to identify the epileptogenic zone in patients with mesial temporal lobe epilepsy.

    DOI: 10.1093/braincomms/fcac023

    PubMed

    researchmap

  • [11C]K-2 image with positron emission tomography represents cell surface AMPA receptors. Reviewed International journal

    Tetsu Arisawa, Tomoyuki Miyazaki, Wataru Ota, Akane Sano, Kumiko Suyama, Yuuki Takada, Takuya Takahashi

    Neuroscience research   173   106 - 113   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) is an important molecule in neurotransmission. We have recently developed the first positron emission tomography (PET) tracer [11C]K-2 to visualize and quantify AMPARs in the living human brain. After injection, [11C]K-2 is hydrolyzed at the terminal amide (and is thus metabolized to a major metabolite, [11C]K-2OH) within 10 min, representing the PET image in rodents and humans. Here, we found that K-2OH did not penetrate the cell membrane but slowly passed through the blood brain barrier (BBB) with paracellular transport. Furthermore, major efflux transporters in the BBB did not carry K-2OH. Logan graphical analysis exhibited reversible binding kinetics of this radiotracer in healthy individuals; these results demonstrated that the PET image of this tracer represents cell surface AMPARs with passive penetration of [11C]K-2OH through the BBB, resulting in reversible binding kinetics. Thus, PET images with this tracer depict the physiologically crucial fraction of AMPARs.

    DOI: 10.1016/j.neures.2021.05.009

    PubMed

    researchmap

  • Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11C]K-2, in healthy human subjects. Reviewed International journal

    Mai Hatano, Tomoyuki Miyazaki, Yoshinobu Ishiwata, Waki Nakajima, Tetsu Arisawa, Yoko Kuroki, Ayako Kobayashi, Yuuki Takada, Matsuyoshi Ogawa, Kazunori Kawamura, Ming-Rong Zhang, Makoto Higuchi, Masataka Taguri, Yasuyuki Kimura, Takuya Takahashi

    Scientific reports   11 ( 1 )   1598 - 1598   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    [11C]K-2, a radiotracer exhibiting high affinity and selectivity for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), is suitable for the quantification of AMPARs in living human brains and potentially useful in the identification of epileptogenic foci in patients. This study aimed to estimate the radiation doses of [11C]K-2 in various organs and calculate the effective dose after injection of [11C]K-2 in healthy human subjects. Twelve healthy male subjects were registered and divided into two groups (370 or 555 MBq of [11C]K-2), followed by 2 h whole-body scans. We estimated the radiation dose of each organ and then calculated the effective dose for each subject. The highest uptake of [11C]K-2 was observed in the liver, while the brain also showed relatively high uptake. The urinary bladder exhibited the highest radiation dose. The kidneys and liver also showed high radiation doses after [11C]K-2 injections. The effective dose of [11C]K-2 ranged from 5.0 to 5.2 μSv/MBq. Our findings suggest that [11C]K-2 is safe in terms of the radiation dose and adverse effects. The injection of 370-555 MBq (10 to 15 mCi) for PET studies using this radiotracer is applicable in healthy human subjects and enables serial PET scans in a single subject.

    DOI: 10.1038/s41598-021-81002-3

    PubMed

    researchmap

    Other Link: http://www.nature.com/articles/s41598-021-81002-3

  • Visualization of AMPA receptors in living human brain with positron emission tomography. Reviewed International journal

    Tomoyuki Miyazaki, Waki Nakajima, Mai Hatano, Yusuke Shibata, Yoko Kuroki, Tetsu Arisawa, Asami Serizawa, Akane Sano, Sayaka Kogami, Tomomi Yamanoue, Kimito Kimura, Yushi Hirata, Yuuki Takada, Yoshinobu Ishiwata, Masaki Sonoda, Masaki Tokunaga, Chie Seki, Yuji Nagai, Takafumi Minamimoto, Kazunori Kawamura, Ming-Rong Zhang, Naoki Ikegaya, Masaki Iwasaki, Naoto Kunii, Yuichi Kimura, Fumio Yamashita, Masataka Taguri, Hideaki Tani, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Masaru Mimura, Michisuke Yuzaki, Hiroki Kato, Makoto Higuchi, Hiroyuki Uchida, Takuya Takahashi

    Nature medicine   26 ( 2 )   281 - 288   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although aberrations in the number and function of glutamate AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors are thought to underlie neuropsychiatric disorders, no methods are currently available for visualizing AMPA receptors in the living human brain. Here we developed a positron emission tomography (PET) tracer for AMPA receptors. A derivative of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide radiolabeled with 11C ([11C]K-2) showed specific binding to AMPA receptors. Our clinical trial with healthy human participants confirmed reversible binding of [11C]K-2 in the brain according to Logan graphical analysis (UMIN000020975; study design: non-randomized, single arm; primary outcome: dynamics and distribution volumes of [11C]K-2 in the brain; secondary outcome: adverse events of [11C]K-2 during the 4-10 d following dosing; this trial met prespecified endpoints). In an exploratory clinical study including patients with epilepsy, we detected increased [11C]K-2 uptake in the epileptogenic focus of patients with mesial temporal lobe epilepsy, which was closely correlated with the local AMPA receptor protein distribution in surgical specimens from the same individuals (UMIN000025090; study design: non-randomized, single arm; primary outcome: correlation between [11C]K-2 uptake measured with PET before surgery and AMPA receptor protein density examined by biochemical study after surgery; secondary outcome: adverse events during the 7 d following PET scan; this trial met prespecified endpoints). Thus, [11C]K-2 is a potent PET tracer for AMPA receptors, potentially providing a tool to examine the involvement of AMPA receptors in neuropsychiatric disorders.

    DOI: 10.1038/s41591-019-0723-9

    PubMed

    researchmap

  • CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage Reviewed

    Hiroki Abe, Susumu Jitsuki, Waki Nakajima, Yumi Murata, Aoi Jitsuki-Takahashi, Yuki Katsuno, Hirobumi Tada, Akane Sano, Kumiko Suyama, Nobuyuki Mochizuki, Takashi Komori, Hitoshi Masuyama, Tomohiro Okuda, Yoshio Goshima, Noriyuki Higo, Takuya Takahashi

    Science   360 ( 6384 )   50 - 57   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Association for the Advancement of Science  

    Brain damage such as stroke is a devastating neurological condition that may severely compromise patient quality of life. No effective medication-mediated intervention to accelerate rehabilitation has been established. We found that a small compound, edonerpic maleate, facilitated experience-driven synaptic glutamate AMPA (a-amino-3hydroxy-5-methyl-4-isoxazole-propionic-acid) receptor delivery and resulted in the acceleration of motor function recovery after motor cortex cryoinjury in mice in a training-dependent manner through cortical reorganization. Edonerpic bound to collapsin-response-mediator-protein 2 (CRMP2) and failed to augment recovery in CRMP2-deficient mice. Edonerpic maleate enhanced motor function recovery from internal capsule hemorrhage in nonhuman primates. Thus, edonerpic maleate, a neural plasticity enhancer, could be a clinically potent small compound with which to accelerate rehabilitation after brain damage.

    DOI: 10.1126/science.aao2300

    Scopus

    PubMed

    researchmap

  • Edonerpic maleate enhances functional recovery from spinal cord injury with cortical reorganization in non-human primates

    Koichi Uramaru, Hiroki Abe, Waki Nakajima, Wataru Ota, Michiaki Suzuki, Osamu Yokoyama, Tetsuya Yamamoto, Yukio Nishimura, Takuya Takahashi

    BRAIN COMMUNICATIONS   7 ( 2 )   2025.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    While spinal cord injury (SCI) aggravates the quality of life in humans by severe paralysis, clinical intervention to promote functional recovery from SCI is limited. We recently identified a small compound, edonerpic maleate (edonerpic MA), which accelerates training-dependent motor functional recovery from brain damage in rodents (cryo-genic cortical injury) and non-human primates (internal capsule haemorrhage) by the facilitation of experience-dependent synaptic trafficking of glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. In the present study, we investigated whether edonerpic MA accelerates functional recovery after SCI in non-human primates. Six adult monkeys (Macaca fuscata) received a unilateral SCI between the C6 and C7 segment. After the SCI, upper limb motor function was immediately impaired and the animals were assigned to receive vehicle (n = 3) or 3 mg/kg/day edonerpic maleate (n = 3) by intramuscular injection for 2 months. The rehabilitative training and evaluation of behaviour using the slit task were performed 5 days a week for 2 months after SCI. The edonerpic MA-treated group showed significantly improved grasping movements than the control group. After recovery reached a plateau, we examined the somatotopic map of the contralesional primary motor cortex (M1) using intracortical microstimulation. The motor representation of wrist territory at contralesional M1 was larger in the edonerpic MA-treated group than in the control group. We concluded that edonerpic MA accelerates the recovery of grasping movements after SCI, accompanied by cortical somatotopic reorganization. Since edonerpic MA enhances recovery from damage in the central nervous system at multiple levels, treatment with edonerpic MA combined with rehabilitative training may represent a novel therapy for not only stroke but also for SCI. Uramaru et al. revealed the efficacy of edonerpic maleate on grasping movement after cervical spinal cord injury and the change of cortical motor representation with intracortical microstimulation in non-human primates. They proposed that edonerpic maleate could be a therapeutic alternative for paralysis after spinal cord injury.See Machado and Hollis (https://doi.org/10.1093/braincomms/fcaf076) for a scientific commentary on this article.

    DOI: 10.1093/braincomms/fcaf036

    Web of Science

    researchmap

  • Edonerpic maleate prevents epileptic seizure during recovery from brain damage by balancing excitatory and inhibitory inputs

    Yuki Katsuno, Susumu Jitsuki, Wataru Ota, Tomomi Yamanoue, Hiroki Abe, Takuya Takahashi

    Frontiers in Neural Circuits   18   2024.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Functional recovery from brain damage, such as stroke, is a plastic process in the brain. The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plays a crucial role in neuronal functions, and the synaptic trafficking of AMPAR is a fundamental mechanism underlying synaptic plasticity. We recently identified a collapsin response mediator protein 2 (CRMP2)-binding compound, edonerpic maleate, which augments rehabilitative training-dependent functional recovery from brain damage by facilitating experience-driven synaptic delivery of AMPARs. In animals recovering from cryogenic brain injury, a potential compensatory area adjacent to the injured region was observed, where the injection of CNQX, an AMPAR antagonist, significantly attenuated functional recovery. In the compensatory brain area of animals recovering from cryogenic injury, the administration of edonerpic maleate enhanced both excitatory and inhibitory synaptic inputs at pyramidal neurons. In contrast, recovered animals that did not receive the drug exhibited augmentation of only excitatory synaptic input. The threshold of picrotoxin-induced epileptic seizure in recovered animals without edonerpic maleate treatment was lower than in intact animals and recovered animals with edonerpic maleate. Thus, edonerpic maleate enhances motor function recovery from brain damage by balancing excitatory and inhibitory synaptic inputs, which helps prevent epileptic seizures during recovery.

    DOI: 10.3389/fncir.2024.1492043

    researchmap

  • AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. Reviewed International journal

    Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Nobuhiro Nagai, Teruki Koizumi, Tomoyuki Miyazaki, Masaru Mimura, Takuya Takahashi, Hiroyuki Uchida

    Schizophrenia research   243   98 - 109   2022.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: While altered expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type receptor has been reported in postmortem studies of schizophrenia, these findings are inconsistent. Therefore, we aimed to systematically review postmortem studies that investigated AMPA receptor expressions in schizophrenia. METHODS: A systematic literature search was conducted for postmortem studies that measured AMPA receptor subunit expressions or receptor bindings in schizophrenia compared to healthy individuals on February 3, 2021, using Medline and Embase. RESULTS: A total of 39 relevant articles were identified from 1360 initial reports. The dorsolateral prefrontal cortex (DLPFC) was the most investigated region (15 studies), followed by the medial temporal lobe (8 studies). For the DLPFC, 4/15 studies (26.7%) showed increased AMPA receptor binding or subunit expression in patients with schizophrenia compared to that in controls, especially in GRIA1 and GRIA4, 2/15 studies (13.3%) reported a decrease, particularly in GRIA2, and 8/15 studies (56.7%) found no significant differences. A decreased expression or receptor binding was observed in 6/8 studies (75.0%) in the subregions of the hippocampus in patients with schizophrenia compared to that in controls, whereas the other two studies found no significant differences. CONCLUSION: Published data have reported decreased subunit expression or receptor binding in the hippocampus in schizophrenia. These findings were inconsistent in other brain regions, which might be due to the heterogeneity of this population, various study design, physiological changes after death, and limited number of studies. Future in vivo studies are warranted to examine AMPA receptor expressions in human brains, together with their comprehensive clinical characterization.

    DOI: 10.1016/j.schres.2022.02.033

    PubMed

    researchmap

  • Phosphorylation of Collapsin Response Mediator Protein 1 (CRMP1) at Tyrosine 504 residue regulates Semaphorin 3A-induced cortical dendritic growth. Reviewed International journal

    Takeshi Kawashima, Aoi Jitsuki-Takahashi, Kohtaro Takizawa, Susumu Jitsuki, Takuya Takahashi, Toshio Ohshima, Yoshio Goshima, Fumio Nakamura

    Journal of Neurochemistry   157 ( 4 )   1207 - 1221   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Collapsin response mediator proteins (CRMPs) have been identified as mediating proteins of repulsive axon guidance cue Semaphorin-3A (Sema3A). Phosphorylation of CRMPs plays a crucial role in the Sema3A signaling cascade. It has been shown that Fyn phosphorylates CRMP1 at Tyrosine 504 residue (Tyr504); however, the physiological role of this phosphorylation has not been examined. We found that CRMP1 was the most strongly phosphorylated by Fyn among the five members of CRMPs. We confirmed Tyr504 phosphorylation of CRMP1 by Fyn. Immunocytochemistry of mouse dorsal root ganglion (DRG) neurons showed that phosphotyrosine signal in the growth cones was transiently increased in the growth cones upon Sema3A stimulation. Tyr504-phosphorylated CRMP1 also tended to increase after Sema3A simulation. Ectopic expression of a single amino acid mutant of CRMP1 replacing Tyr504 with phenylalanine (CRMP1-Tyr504Phe) suppressed Sema3A-induced growth cone collapse response in chick DRG neurons. CRMP1-Tyr504Phe expression in mouse hippocampal neurons also suppressed Sema3A but not Sema3F-induced growth cone collapse response. Immunohistochemistry showed that Tyr504-phosphorylated CRMP1 was present in the cell bodies and in the dendritic processes of mouse cortical neurons. CRMP1-Tyr504Phe suppressed Sema3A-induced dendritic growth of primary cultured mouse cortical neurons as well as the dendritic development of cortical pyramidal neurons in vivo. Fyn± ; Crmp1± double heterozygous mutant mice exhibited poor development of cortical layer V basal dendrites, which was the similar phenotype observed in Sema3a-/- , Fyn-/- , and Crmp1-/- mice. These findings demonstrate that Tyr504 phosphorylation of CRMP1 by Fyn is an essential step of Sema3A-regulated dendritic development of cortical pyramidal neurons. (247 words).

    DOI: 10.1111/jnc.15304

    PubMed

    researchmap

  • Activity-induced secretion of semaphorin 3A mediates learning. Reviewed International journal

    Aoi Jitsuki-Takahashi, Susumu Jitsuki, Naoya Yamashita, Meiko Kawamura, Manabu Abe, Kenji Sakimura, Akane Sano, Fumio Nakamura, Yoshio Goshima, Takuya Takahashi

    The European journal of neuroscience   53 ( 10 )   3279 - 3293   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The semaphorin family is a well-characterized family of secreted or membrane-bound proteins that are involved in activity-independent neurodevelopmental processes, such as axon guidance, cell migration, and immune functions. Although semaphorins have recently been demonstrated to regulate activity-dependent synaptic scaling, their roles in Hebbian synaptic plasticity as well as learning and memory remain poorly understood. Here, using a rodent model, we found that an inhibitory avoidance task, a hippocampus-dependent contextual learning paradigm, increased secretion of semaphorin 3A in the hippocampus. Furthermore, the secreted semaphorin 3A in the hippocampus mediated contextual memory formation likely by driving AMPA receptors into hippocampal synapses via the neuropilin1-plexin A4-semaphorin receptor complex. This signaling process involves alteration of the phosphorylation status of collapsin response mediator protein 2, which has been characterized as a downstream molecule in semaphorin signaling. These findings implicate semaphorin family as a regulator of Hebbian synaptic plasticity and learning.

    DOI: 10.1111/ejn.15210

    PubMed

    researchmap

  • Translational medicine of the glutamate AMPA receptor. Reviewed

    Miyazaki T, Abe H, Uchida H, Takahashi T

    Proceedings of the Japan Academy. Series B, Physical and biological sciences   97 ( 1 )   1 - 21   2021.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Japan Academy  

    Psychiatric and neurological disorders severely hamper patient's quality of life. Despite their high unmet needs, the development of diagnostics and therapeutics has only made slow progress. This is due to limited evidence on the biological basis of these disorders in humans. Synapses are essential structural units of neurotransmission, and neuropsychiatric disorders are considered as "synapse diseases". Thus, a translational approach with synaptic physiology is crucial to tackle these disorders. Among a variety of synapses, excitatory glutamatergic synapses play central roles in neuronal functions. The glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a principal component of glutamatergic neurotransmission; therefore, it is considered to be a promising translational target. Here, we review the limitations of current diagnostics and therapeutics of neuropsychiatric disorders and advocate the urgent need for the promotion of translational medicine based on the synaptic physiology of AMPAR. Furthermore, we introduce our recent translational approach to these disorders by targeting at AMPARs.

    DOI: 10.2183/pjab.97.001

    PubMed

    researchmap

  • 神経疾患の「機能回復ネットワーク」の探索

    阿部 弘基, 高橋 琢哉

    Medical Science Digest   46 ( 10 )   634 - 637   2020.9

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    根本的治療法が存在しない神経疾患では機能障害の後遺は避け難い。機能障害を改善・代償するには疾患の進行や再発を抑制する治療に加えて、リハビリテーションが重要である。近年、脳卒中に限らず、脊髄小脳変性症、パーキンソン病、多発性硬化症といった慢性進行性疾患でもリハビリテーション法の改良が試みられている。脳神経科学ではリハビリテーションによる機能回復は非障害脳領域における機能的再構築に依拠するとされてきたが、ヒト生体脳において疾患毎の機能回復能の神経生理学的理解は不十分である。我々は、急性脳損傷モデルにおいて、グルタミン酸AMPA受容体のシナプス後膜への移行促進がリハビリテーションによる運動機能回復を促進することを薬理学的に示した。現在はこの研究に動機づけられ、PET画像で得られるAMPA受容体発現密度分布を手掛かりとして、リハビリテーションを可能とする「機能回復ネットワーク」の疾患横断的解明に取り組んでいる。(著者抄録)

    researchmap

  • Novel synaptic plasticity enhancer drug to augment functional recovery with rehabilitation. Reviewed International journal

    Takuya Takahashi

    Current opinion in neurology   32 ( 6 )   822 - 827   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE OF REVIEW: Stroke is a devastating illness which severely attenuates quality of life because of paralysis. Despite recent advances in therapies during acute phase such as thrombolytic therapy, clinical option to intervene the process of rehabilitation is limited. No pharmacological intervention that could enhance the effect of rehabilitation has not been established. Recent articles, which are summarized in the review article, reported novel small compound which accelerates training-dependent motor function recovery after brain damage. RECENT FINDINGS: A novel small compound, edonerpic maleate, binds to collapsin response mediator protein 2 (CRMP2) and enhance synaptic plasticity leading to the acceleration of rehabilitative training-dependent functional recovery after brain damage in rodent and nonhuman primate. The clinical trial to test this effect in human is now ongoing. Future preclinical and clinical studies will delineate the potentials of this compound. SUMMARY: A novel CRMP2-binding small compound, edonerpic maleate, accelerates motor function recovery after brain damage in rodent and nonhuman primate.

    DOI: 10.1097/WCO.0000000000000748

    PubMed

    researchmap

  • Pharmacological Enhancement of Stroke Rehabilitation. Reviewed International journal

    Hiroki Abe, Susumu Jitsuki, Takuya Takahashi

    Stroke   50 ( 11 )   3323 - 3329   2019.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1161/STROKEAHA.119.023720

    PubMed

    researchmap

  • Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies. International journal

    Fumihiko Ueno, Takefumi Suzuki, Shinichiro Nakajima, Sachio Matsushita, Masaru Mimura, Tomoyuki Miyazaki, Takuya Takahashi, Hiroyuki Uchida

    Neuropsychopharmacology reports   39 ( 3 )   148 - 155   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Neuropsychopharmacology Reports  

    BACKGROUND AND OBJECTIVES: Altered trafficking of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors has been reported in postmortem studies and suggested the involvement of AMPA receptors in the pathophysiology underpinning addictive disorders. However, these findings seemed mixed. METHODS: A systematic literature search was conducted, using PubMed and Embase (last search, August 2018), to identify human postmortem studies that examined the expression of proteins and mRNA of AMPA receptor subunits in patients with addictive disorders in comparison with healthy controls. RESULTS: Twelve (18 studies) out of 954 articles were identified to be relevant. Eight studies included alcohol use disorders, and four studies included heroin/cocaine abusers. The most frequently investigated regions were the hippocampus (three studies), amygdala (three studies), and putamen (three studies). In summary, two out of the three studies showed an increase in the expression of AMPA receptors in the hippocampus, while the other study found no change. Two studies to examine the amygdala demonstrated either a decreased or no change in receptor expression or binding. Concerning putamen, two studies showed no significant change whereas an overexpression of receptors was observed in the other. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: The hippocampus and amygdala may be pertinent to addictive disorders through their functions on learning and memory, whereas findings in other regions were inconsistent across the studies. Human postmortem studies are prone to degenerative changes after death. Moreover, only qualitative assessment was conducted because of the limited, heterogenous data. These limitations emphasize the need to investigate AMPA receptors in the living human brains.

    DOI: 10.1002/npr2.12058

    PubMed

    researchmap

  • Comparison of emotional processing assessed with fear conditioning by interpersonal conflicts in patients with depression and schizophrenia. Reviewed International journal

    Tani H, Tada M, Maeda T, Konishi M, Umeda S, Terasawa Y, Mimura M, Takahashi T, Uchida H

    Psychiatry and clinical neurosciences   73 ( 3 )   116 - 125   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: While emotional processing is implicated in various psychiatric illnesses, its differences among diagnoses are unclear. We compared associative learning of social values in patients with depression and schizophrenia by measuring skin conductance response to interpersonal stimuli. METHODS: We included 20 female outpatients each with depression and schizophrenia. They underwent Pavlovian conditioning experiments in response to a classical aversive sound, and an interpersonal stimulus that was designed to cause aversive social conditioning with actors' faces coupled with negative verbal messages. Multiple regression analysis was performed to examine the associations between the degree of conditioned response and the clinical characteristics of the participants. RESULTS: Conditioned responses during the acquisition phase in both conditions were higher in depression compared to schizophrenia. Patients with depression successfully showed fear conditioning in both conditions, and they exhibited slower extinction in the interpersonal condition. The conditioned response during the extinction phase showed a positive association with Emotion Regulation Questionnaire Expressive Suppression score, and a negative association with the Emotion Regulation Questionnaire Cognitive Reappraisal score and the use of antidepressants. Patients with schizophrenia did not become conditioned in either of the conditions. The Positive and Negative Syndrome Scale Negative Syndrome score was negatively associated with the degree of conditioned response during the acquisition phase in the interpersonal condition. CONCLUSION: Female patients with schizophrenia, especially those who prominently demonstrated negative symptoms, suggested their intrinsic impairments in the associative learning of social context. Antidepressants and adaptive emotional regulation strategy may enhance the extinction learning of aversive social conditioning in depression.

    DOI: 10.1111/pcn.12805

    PubMed

    researchmap

  • Punishment-Predictive Cues Guide Avoidance through Potentiation of Hypothalamus-to-Habenula Synapses. Reviewed

    Trusel M, Nuno-Perez A, Salvatore Lecca, Harumi Harada, Arnaud Lalive, Mauro Congiu, Kiwamu Takemoto, Takahashi T, Francesco Ferraguti, Mameli M

    Neuron   102 ( 1 )   120 - 127.e4   2019.2

     More details

    Publishing type:Research paper (scientific journal)  

    Throughout life, individuals learn to predict a punishment via its association with sensory stimuli. This process ultimately prompts goal-directed actions to prevent the danger, a behavior defined as avoidance. Neurons in the lateral habenula (LHb) respond to aversive events as well as to environmental cues predicting them, supporting LHb contribution to cue-punishment association. However, whether synaptic adaptations at discrete habenular circuits underlie such associative learning to instruct avoidance remains elusive. Here, we find that, in mice, contingent association of an auditory cue (tone) with a punishment (foot shock) progressively causes cue-driven LHb neuronal excitation during avoidance learning. This process is concomitant with the strengthening of LHb AMPA receptor-mediated neurotransmission. Such a phenomenon occludes long-term potentiation and occurs specifically at hypothalamus-to-habenula synapses. Silencing hypothalamic-to-habenulainputs or optically inactivating postsynaptic AMPA receptors within the LHb disrupts avoidance learning. Altogether, synaptic strengthening at a discrete habenular circuit transforms neutral stimuli into salient punishment-predictive cues to guide avoidance.

    DOI: 10.1016/j.neuron.2019.01.025

    PubMed

    researchmap

  • Social isolation suppresses actin dynamics and synaptic plasticity through ADF/cofilin inactivation in the developing rat barrel cortex Reviewed

    Hirobumi Tada, Tomoyuki Miyazaki, Kiwamu Takemoto, Susumu Jitsuki, Waki Nakajima, Mayu Koide, Naoko Yamamoto, Akiko Taguchi, Honami Kawai, Kasane Komiya, Kumiko Suyama, Hiroki Abe, Akane Sano, Takuya Takahashi

    SCIENTIFIC REPORTS   7 ( 1 )   8471   2017.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Exposure to a stressful environment early in life can cause psychiatric disorders by disrupting circuit formation. Actin plays central roles in regulating neuronal structure and protein trafficking. We have recently reported that neonatal isolation inactivated ADF/cofilin, the actin depolymerizing factor, resulted in a reduced actin dynamics at spines and an attenuation of synaptic alpha-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid (AMPA) receptor delivery in the juvenile rat medial prefrontal cortex (mPFC), leading to altered social behaviours. Here, we investigated the impact of neonatal social isolation in the developing rat barrel cortex. Similar to the mPFC study, we detected an increase in stable actin fraction in spines and this resulted in a decreased synaptic AMPA receptor delivery. Thus, we conclude that early life social isolation affects multiple cortical areas with common molecular changes.

    DOI: 10.1038/s41598-017-08849-3

    Web of Science

    PubMed

    researchmap

  • Optical inactivation of synaptic AMPA receptors erases fear memory Reviewed

    Kiwamu Takemoto, Hiroko Iwanari, Hirobumi Tada, Kumiko Suyama, Akane Sano, Takeharu Nagai, Takao Hamakubo, Takuya Takahashi

    NATURE BIOTECHNOLOGY   35 ( 1 )   38 - 47   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The synaptic delivery of neurotransmitter receptors, such as GluA1 AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors, mediates important processes in cognitive function, including memory acquisition and retention. Understanding the roles of these receptors has been hampered by the lack of a method to inactivate them in vivo with high spatiotemporal precision. We developed a technique to inactivate synaptic GIuA1 AMPA receptors in vivo using chromophore-assisted light inactivation (CALI). We raised a monoclonal antibody specific for the extracellular domain of GluA1 that induced effective CALI when conjugated with a photosensitizer (eosin). Mice that had been injected in the CA1 hippocampal region with the antibody conjugate underwent a fear memory task. Exposing the hippocampus to green light using an implanted cannula erased acquired fear memory in the animals by inactivation of synaptic GluA1. Our optical technique for inactivating synaptic proteins will enable elucidation of their physiological roles in cognition.

    DOI: 10.1038/nbt.3710

    Web of Science

    PubMed

    researchmap

  • Neonatal isolation augments social dominance by altering actin dynamics in the medial prefrontal cortex Reviewed

    Hirobumi Tada, Tomoyuki Miyazaki, Kiwamu Takemoto, Kenkichi Takase, Susumu Jitsuki, Waki Nakajima, Mayu Koide, Naoko Yamamoto, Kasane Komiya, Kumiko Suyama, Akane Sano, Akiko Taguchi, Takuya Takahashi

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   113 ( 45 )   E7097 - E7105   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    Social separation early in life can lead to the development of impaired interpersonal relationships and profound social disorders. However, the underlying cellular and molecular mechanisms involved are largely unknown. Here, we found that isolation of neonatal rats induced glucocorticoid-dependent social dominance over nonisolated control rats in juveniles from the same litter. Furthermore, neonatal isolation inactivated the actin-depolymerizing factor (ADF)/cofilin in the juvenile medial prefrontal cortex (mPFC). Isolation-induced inactivation of ADF/cofilin increased stable actin fractions at dendritic spines in the juvenile mPFC, decreasing glutamate synaptic AMPA receptors. Expression of constitutively active ADF/cofilin in the mPFC rescued the effect of isolation on social dominance. Thus, neonatal isolation affects spines in the mPFC by reducing actin dynamics, leading to altered social behavior later in life.

    DOI: 10.1073/pnas.1606351113

    Web of Science

    PubMed

    researchmap

  • Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines

    Koki Fujimori, Toshiki Tezuka, Hiroyuki Ishiura, Jun Mitsui, Koichiro Doi, Jun Yoshimura, Hirobumi Tada, Takuya Matsumoto, Miho Isoda, Ryota Hashimoto, Nubutaka Hattori, Takuya Takahashi, Shinichi Morishita, Shoji Tsuji, Wado Akamatsu, Hideyuki Okano

    MOLECULAR BRAIN   9   88   2016.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Patient-specific induced pluripotent stem cells (iPSCs) facilitate understanding of the etiology of diseases, discovery of new drugs and development of novel therapeutic interventions. A frequently used starting source of cells for generating iPSCs has been dermal fibroblasts (DFs) isolated from skin biopsies. However, there are also numerous repositories containing lymphoblastoid B-cell lines (LCLs) generated from a variety of patients. To date, this rich bioresource of LCLs has been underused for generating iPSCs, and its use would greatly expand the range of targeted diseases that could be studied by using patient-specific iPSCs. However, it remains unclear whether patient's LCL-derived iPSCs (LiPSCs) can function as a disease model. Therefore, we generated Parkinson's disease patient-specific LiPSCs and evaluated their utility as tools for modeling neurological diseases. We established iPSCs from two LCL clones, which were derived from a healthy donor and a patient carrying PARK2 mutations, by using existing non-integrating episomal protocols. Whole genome sequencing (WGS) and comparative genomic hybridization (CGH) analyses showed that the appearance of somatic variations in the genomes of the iPSCs did not vary substantially according to the original cell types (LCLs, T-cells and fibroblasts). Furthermore, LiPSCs could be differentiated into functional neurons by using the direct neurosphere conversion method (dNS method), and they showed several Parkinson's disease phenotypes that were similar to those of DF-iPSCs. These data indicate that the global LCL repositories can be used as a resource for generating iPSCs and disease models. Thus, LCLs are the powerful tools for generating iPSCs and modeling neurological diseases.

    DOI: 10.1186/s13041-016-0267-6

    Web of Science

    researchmap

  • Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling Reviewed

    Takuya Matsumoto, Koki Fujimori, Tomoko Andoh-Noda, Takayuki Ando, Naoko Kuzumaki, Manabu Toyoshima, Hirobumi Tada, Kent Imaizumi, Mitsuru Ishikawa, Ryo Yamaguchi, Miho Isoda, Zhi Zhou, Shigeto Sato, Tetsuro Kobayashi, Manami Ohtaka, Ken Nishimura, Hiroshi Kurosawa, Takeo Yoshikawa, Takuya Takahashi, Mahito Nakanishi, Manabu Ohyama, Nobutaka Hattori, Wado Akamatsu, Hideyuki Okano

    STEM CELL REPORTS   6 ( 3 )   422 - 435   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Modeling of neurological diseases using induced pluripotent stem cells (iPSCs) derived from the somatic cells of patients has provided a means of elucidating pathogenic mechanisms and performing drug screening. T cells are an ideal source of patient-specific iPSCs because they can be easily obtained from samples. Recent studies indicated that iPSCs retain an epigenetic memory relating to their cell of origin that restricts their differentiation potential. The classical method of differentiation via embryoid body formation was not suitable for T cell-derived iPSCs (TiPSCs). We developed a neurosphere-based robust differentiation protocol, which enabled TiPSCs to differentiate into functional neurons, despite differences in global gene expression between TiPSCs and adult human dermal fibroblast-derived iPSCs. Furthermore, neurons derived from TiPSCs generated from a juvenile patient with Parkinson's disease exhibited several Parkinson's disease phenotypes. Therefore, we conclude that TiPSCs are a useful tool for modeling neurological diseases.

    DOI: 10.1016/j.stemcr.2016.01.010

    Web of Science

    researchmap

  • Sustained Enhancement of Lateral Inhibitory Circuit Maintains Cross Modal Cortical Reorganization Reviewed

    Waki Nakajima, Susumu Jitsuki, Akane Sano, Takuya Takahashi

    PLOS ONE   11 ( 2 )   e0149068.   2016.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Deprivation of one modality can lead to the improvement of other intact modalities. We have previously reported that visual deprivation drives AMPA receptors into synapses from layer4 to 2/3 in the barrel cortex and sharpens functional whisker-barrel map at layer2/3 2 days after the beginning of visual deprivation. Enhanced excitatory synaptic transmission at layer4-2/3 synapses is transient and returns to the base line level a week after the beginning of visual deprivation. Here we found that sharpened whisker-barrel function is maintained at least for a week in visually deprived animals. While increased AMPA receptor-mediated synaptic transmission at layer4-2/3 synapses dropped to the base line a week after the beginning of visual deprivation, lateral inhibitory synaptic transmission onto the neighboring barrel was kept strengthened for a week of visually deprived animals. Thus, transient strengthening of excitatory synapses at layer4-2/3 in the barrel cortex could trigger the enhancement of inhibitory inputs to neighboring barrel, and sustained lateral inhibition can maintain the sharpening of whisker-barrel map in visually deprived animals.

    DOI: 10.1371/journal.pone.0149068

    Web of Science

    researchmap

  • Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery. Reviewed

    Jitsuki S, Nakajima W, Kiwamu Takemoto, Sano A, Tada H, Takahashi-Jitsuki A, Takahashi T

    Cerebral cortex (New York, N.Y. : 1991)   doi: 10.1093 ( bhv232 )   2015.10

     More details

    Publishing type:Research paper (scientific journal)  

    Experience-dependent plasticity is limited in the adult brain, and its molecular and cellular mechanisms are poorly understood. Removal of the myelin-inhibiting signaling protein, Nogo receptor (NgR1), restores adult neural plasticity. Here we found that, in NgR1-deficient mice, whisker experience-driven synaptic α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) insertion in the barrel cortex, which is normally complete by 2 weeks after birth, lasts into adulthood. In vivo live imaging by two-photon microscopy revealed more AMPAR on the surface of spines in the adult barrel cortex of NgR1-deficient than on those of wild-type (WT) mice. Furthermore, we observed that whisker stimulation produced new spines in the adult barrel cortex of mutant but not WT mice, and that the newly synthesized spines contained surface AMPAR. These results suggest that Nogo signaling limits plasticity by restricting synaptic AMPAR delivery in coordination with anatomical plasticity.

    DOI: 10.1093/cercor/bhv232

    PubMed

    researchmap

  • Estrous Cycle-Dependent Phasic Changes in the Stoichiometry of Hippocampal Synaptic AMPA Receptors in Rats Reviewed

    Hirobumi Tada, Mayu Koide, Wakana Ara, Yusuke Shibata, Toshiya Funabashi, Kumiko Suyama, Takahisa Goto, Takuya Takahashi

    PLOS ONE   10 ( 6 )   e0131359   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Cognitive function can be affected by the estrous cycle. However, the effect of the estrous cycle on synaptic functions is poorly understood. Here we show that in female rats, inhibitory-avoidance (IA) task (hippocampus-dependent contextual fear-learning task) drives GluA2-lacking Ca2+-permeable AMPA receptors (CP-AMPARs) into the hippocampal CA3-CA1 synapses during all periods of the estrous cycle except the proestrous period, when estrogen levels are high. In addition, IA task failed to drive CP-AMPARs into the CA3-CA1 synapses of ovariectomized rats only when estrogen was present. Thus, changes in the stoichiometry of AMPA receptors during learning depend on estrogen levels. Furthermore, the induction of long-term potentiation (LTP) after IA task was prevented during the proestrous period, while intact LTP is still expressed after IA task during other period of the estrous cycle. Consistent with this finding, rats conditioned by IA training failed to acquire hippocampus-dependent Y-maze task during the proestrous period. On the other hand, during other estrous period, rats were able to learn Y-maze task after IA conditioning. These results suggest that high estrogen levels prevent the IA learning-induced delivery of CP-AMPARs into hippocampal CA3-CA1 synapses and limit synaptic plasticity after IA task, thus preventing the acquisition of additional learning.

    DOI: 10.1371/journal.pone.0131359

    Web of Science

    researchmap

  • Fear Conditioning Induced by Interpersonal Conflicts in Healthy Individuals Reviewed

    Mitsuhiro Tada, Hiroyuki Uchida, Takaki Maeda, Mika Konishi, Satoshi Umeda, Yuri Terasawa, Shinichiro Nakajima, Masaru Mimura, Tomoyuki Miyazaki, Takuya Takahashi

    PLOS ONE   10 ( 5 )   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Psychophysiological markers have been focused to investigate the psychopathology of psychiatric disorders and personality subtypes. In order to understand neurobiological mechanisms underlying these conditions, fear-conditioning model has been widely used. However, simple aversive stimuli are too simplistic to understand mechanisms because most patients with psychiatric disorders are affected by social stressors. The objective of this study was to test the feasibility of a newly-designed conditioning experiment using a stimulus to cause interpersonal conflicts and examine associations between personality traits and response to that stimulus. Twenty-nine healthy individuals underwent the fear conditioning and extinction experiments in response to three types of stimuli: a simple aversive sound, disgusting pictures, and pictures of an actors' face with unpleasant verbal messages that were designed to cause interpersonal conflicts. Conditioned response was quantified by the skin conductance response (SCR). Correlations between the SCR changes, and personality traits measured by the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) and Revised NEO Personality Inventory were explored. The interpersonal conflict stimulus resulted in successful conditioning, which was subsequently extinguished, in a similar manner as the other two stimuli. Moreover, a greater degree of conditioned response to the interpersonal conflict stimulus correlated with a higher ZAN-BPD total score. Fear conditioning and extinction can be successfully achieved, using interpersonal conflicts as a stimulus. Given that conditioned fear caused by the interpersonal conflicts is likely associated with borderline personality traits, this paradigm could contribute to further understanding of underlying mechanisms of interpersonal fear implicated in borderline personality disorder.

    DOI: 10.1371/journal.pone.0125729

    Web of Science

    researchmap

  • Isoflurane Impairs Learning and Hippocampal Long-term Potentiation via the Saturation of Synaptic Plasticity Reviewed

    Kazuhiro Uchimoto, Tomoyuki Miyazaki, Yoshinori Kamiya, Takahiro Mihara, Yukihide Koyama, Masataka Taguri, Gaku Inagawa, Takuya Takahashi, Takahisa Goto

    ANESTHESIOLOGY   121 ( 2 )   302 - 310   2014.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Background: General anesthesia induces long-lasting cognitive and learning deficits. However, the underlying mechanism remains unknown. The GluA1 subunit of AMPAR is a key molecule for learning and synaptic plasticity, which requires trafficking of GluA1-containing AMPARs into the synapse.
    Methods: Adult male rats were exposed to 1.8% isoflurane for 2 h and subjected to an inhibitory avoidance task, which is a hippocampus-dependent contextual fear learning paradigm (n = 16 to 39). The in vitro extracellular field potential of hippocampal synapses between the Schaffer collateral and the CA1 was evaluated using a multielectrode recorder (n = 6 per group). GluA1 expression in the synaptoneurosome was assessed using Western blotting (n = 5 to 8). The ubiquitination level of GluA1 was evaluated using immunoprecipitation and Western blotting (n = 7 per group).
    Results: Seven days after exposure to 1.8% isoflurane for 2 h (Iso(1.8)), the inhibitory avoidance learning (control vs. Iso(1.8); 294 +/- 34 vs. 138 +/- 28, the mean +/- SEM [%]; P = 0.002) and long-term potentiation (125.7 +/- 6.1 vs. 105.7 +/- 3.3; P &lt; 0.001) were impaired. Iso(1.8) also temporarily increased GluA1 in the synaptoneurosomes (100 +/- 9.7 vs. 138.9 +/- 8.9; P = 0.012) and reduced the GluA1 ubiquitination, a main degradation pathway of GluA1 (100 +/- 8.7 vs. 71.1 +/- 6.1; P = 0.014).
    Conclusions: Isoflurane impairs hippocampal learning and modulates synaptic plasticity in the postanesthetic period. Increased GluA1 may reduce synaptic capacity for additional GluA1-containing AMPARs trafficking.

    DOI: 10.1097/ALN.0000000000000269

    Web of Science

    researchmap

  • Phasic synaptic incorporation of GluR2-lacking AMPA receptors at gonadotropin-releasing hormone neurons is involved in the generation of the luteinizing hormone surge in female rats Reviewed

    H. Tada, Y. Kuroki, T. Funabashi, Y. Kamiya, T. Goto, K. Suyama, A. Sano, D. Mitsushima, A. M. Etgen, T. Takahashi

    Neuroscience   248   664 - 669   2013.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Reproductive success depends on a robust and appropriately timed preovulatory luteinizing hormone (LH) surge, which is induced by the activation of gonadotropin-releasing hormone (GnRH) neurons in response to positive feedback from increasing estrogen levels. Here we document an increase in postsynaptic GluR2-lacking Ca2+-permeable AMPA-type glutamate receptors (CP-AMPARs) at synapses on GnRH neurons on the day of proestrus in rats, coincident with the increase in estrogen levels. Functional blockade of CP-AMPARs depressed the synaptic responses only on the day of proestrus and concomitantly attenuated the LH surge. Thus, the phasic synaptic incorporation of postsynaptic CP-AMPARs on GnRH neurons is involved in the generation of the LH surge. © 2013 The Authors.

    DOI: 10.1016/j.neuroscience.2013.06.040

    Scopus

    PubMed

    researchmap

  • Social isolation perturbs experience-driven synaptic glutamate receptor subunit 4 delivery in the developing rat barrel cortex Reviewed

    Tomoyuki Miyazaki, Misako Kunii, Susumu Jitsuki, Akane Sano, Yoshiyuki Kuroiwa, Takuya Takahashi

    EUROPEAN JOURNAL OF NEUROSCIENCE   37 ( 10 )   1602 - 1609   2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    In neonates, the stress of social isolation can alter developing neural circuits and cause mental illness. However, the molecular and cellular bases for these effects are poorly understood. Experience-driven synaptic AMPA receptor delivery is crucial for circuit organisation during development. In the rat, whisker experience drives the delivery of glutamate receptor subunit 4 (GluA4) but not glutamate receptor subunit 1 (GluA1) to layer 42/3 pyramidal synapses in the barrel cortex during postnatal day (P)810, whereas GluA1 but not GluA4 is delivered to these synapses during P1214. We recently reported that early social isolation disrupts experience-driven GluA1 delivery to layer 42/3 pyramidal synapses during P1214. Here, we report that neonatal isolation affects even earlier stages of development by preventing experience-dependent synaptic GluA4 delivery. Thus, social isolation severely affects synaptic maturation throughout early postnatal development.

    DOI: 10.1111/ejn.12188

    Web of Science

    PubMed

    researchmap

  • A cholinergic trigger drives learning-induced plasticity at hippocampal synapses Reviewed

    Dai Mitsushima, Akane Sano, Takuya Takahashi

    Nature Communications   4   2760   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Nature Publishing Group  

    Learning induces plastic changes in synapses. However, the regulatory molecules that orchestrate learning-induced synaptic changes are largely unknown. Although it is well established that cholinergic inputs from the medial septum modulate learning and memory, evidence for the cholinergic regulation of learning-induced synaptic plasticity is lacking. Here we find that the activation of muscarinic acetylcholine (ACh) receptors (mAChRs) mediates the contextual fear learning-driven strengthening of hippocampal excitatory pyramidal synapses through the synaptic incorporation of AMPA-type glutamate receptors (AMPARs). Contextual fear learning also enhances the strength of inhibitory synapses on hippocampal pyramidal CA1 neurons, in a manner mediated by the activation of, not mAChRs, but, nicotinic AChRs (nAChRs). We observe a significant correlation between the learning-induced increases in excitatory and inhibitory synaptic strength at individual pyramidal neurons. Understanding the mechanisms underlying cholinergic regulation of learning-induced hippocampal synaptic plasticity may help the development of new therapies for cognitive disorders. © 2013 Macmillan Publishers Limited. All rights reserved.

    DOI: 10.1038/ncomms3760

    Scopus

    PubMed

    researchmap

  • Disrupted cortical function underlies behavior dysfunction due to social isolation Reviewed

    Tomoyuki Miyazaki, Kenkichi Takase, Waki Nakajima, Hirobumi Tada, Daisuke Ohya, Akane Sano, Takahisa Goto, Hajime Hirase, Roberto Malinow, Takuya Takahashi

    JOURNAL OF CLINICAL INVESTIGATION   122 ( 7 )   2690 - 2701   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC CLINICAL INVESTIGATION INC  

    Stressful events during early childhood can have a profound lifelong influence on emotional and cognitive behaviors. However, the mechanisms by which stress affects neonatal brain circuit formation are poorly understood. Here, we show that neonatal social isolation disrupts molecular, cellular, and circuit developmental processes, leading to behavioral dysfunction. Neonatal isolation prevented long-term potentiation and experience-dependent synaptic trafficking of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors normally occurring during circuit formation in the rodent barrel cortex. This inhibition of AMPA receptor trafficking was mediated by an increase of the stress glucocorticoid hormone and was associated with reduced calcium/calmodulin-dependent protein kinase type II (CaMKII) signaling, resulting in attenuated whisker sensitivity at the cortex. These effects led to defects in whisker-dependent behavior in juvenile animals. These results indicate that neonatal social isolation alters neuronal plasticity mechanisms and perturbs the initial establishment of a normal cortical circuit, which potentially explains the long-lasting behavioral effects of neonatal stress.

    DOI: 10.1172/JCI63060

    Web of Science

    PubMed

    researchmap

  • Developmental AMPA receptor subunit specificity during experience-driven synaptic plasticity in the rat barrel cortex Reviewed

    Tomoyuki Miyazaki, Misako Kunii, Hirobumi Tada, Akane Sano, Yoshiyuki Kuroiwa, Takahisa Goto, Roberto Malinow, Takuya Takahashi

    BRAIN RESEARCH   1435   1 - 7   2012.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    During early postnatal brain development, experience-driven delivery of AMPA receptors to synapses participates in the initial organization of conical function. By combining virus-mediated in vivo gene delivery with in vitro whole cell recordings, we identified a subunit-specific developmental program of experience-driven AMPA receptor delivery to synapses in rat barrel cortex. We expressed green fluorescent protein (GFP)-tagged AMPA receptors (GFP-GluR1, or GFP-GluR4) into layer 2/3 pyramidal neurons at two distinct developmental periods, postnatal day (P)8-P10 and P12-P14. Two days after viral infection, acute brain slices were prepared, and synaptic transmission from layer 4 to layer 2/3 was analyzed by whole cell recordings. We found that whisker experience drives GluR4 but not GluR1 into these synapses early in postnatal development (P8-1310). However, at P12-14, GluR1 but not GluR4 is delivered into synapses by whisker experience. This precise developmental plan suggests unique plasticity properties endowed in different AMPA receptor subunits which shape the initial experience-driven organization of cortical function. (C) 2011 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.brainres.2011.11.033

    Web of Science

    PubMed

    researchmap

  • Mechanisms underlying contextual fear learning. Reviewed

    Takahashi T

    Communicative & integrative biology   4   726 - 727   2011.11

     More details

    Publisher:6  

    PubMed

    researchmap

  • Serotonin as a mediator of cross-modal cortical reorganization. Reviewed

    Takahashi T

    Communicative & integrative biology   4   459 - 461   2011.7

     More details

  • Contextual learning requires synaptic AMPA receptor delivery in the hippocampus Reviewed

    Dai Mitsushima, Kouji Ishihara, Akane Sano, Helmut W. Kessels, Takuya Takahashi

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   108 ( 30 )   12503 - 12508   2011.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    The hippocampus plays a central role in learning and memory. Although synaptic delivery of AMPA-type glutamate receptors (AMPARs) contributes to experience-dependent synaptic strengthening, its role in hippocampus-dependent learning remains elusive. By combining viral-mediated in vivo gene delivery with in vitro patch-clamp recordings, we found that the inhibitory avoidance task, a hippocampus-dependent contextual fear-learning paradigm, delivered GluR1-containing AMPARs into CA3-CA1 synapses of the dorsal hippocampus. To block the synaptic delivery of endogenous AMPARs, we expressed a fragment of the GluR1-cytoplasmic tail (the 14-aa GluR1 membrane-proximal region with two serines mutated to phospho-mimicking aspartates: MPR-DD). MPR-DD prevented learning-driven synaptic AMPAR delivery in CA1 neurons. Bilateral expression of MPR-DD in the CA1 region of the rat impaired inhibitory avoidance learning, indicating that synaptic GluR1 trafficking in the CA1 region of the hippocampus is required for encoding contextual fear memories. The fraction of CA1 neurons that underwent synaptic strengthening positively correlated with the performance in the inhibitory avoidance fear memory task. These data suggest that the robustness of a contextual memory depends on the number of hippocampal neurons that participate in the encoding of a memory trace.

    DOI: 10.1073/pnas.1104558108

    Web of Science

    PubMed

    researchmap

  • Serotonin Mediates Cross-Modal Reorganization of Cortical Circuits Reviewed

    Susumu Jitsuki, Kiwamu Takemoto, Taisuke Kawasaki, Hirobumi Tada, Aoi Takahashi, Carine Becamel, Akane Sano, Michisuke Yuzaki, R. Suzanne Zukin, Edward B. Ziff, Helmut W. Kessels, Takuya Takahashi

    NEURON   69 ( 4 )   780 - 792   2011.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Loss of one type of sensory input can cause improved functionality of other sensory systems. Whereas this form of plasticity, cross-modal plasticity, is well established, the molecular and cellular mechanisms underlying it are still unclear. Here, we show that visual deprivation (VD) increases extracellular serotonin in the juvenile rat barrel cortex. This increase in serotonin levels facilitates synaptic strengthening at layer 4 to layer 2/3 synapses within the barrel cortex. Upon VD, whisker experience leads to trafficking of the AMPA-type glutamate receptors (AMPARs) into these synapses through the activation of ERK and increased phosphorylation of AMPAR subunit GluR1 at the juvenile age when natural whisker experience no longer induces synaptic GluR1 delivery. VD thereby leads to sharpening of the functional whisker-barrel map at layer 2/3. Thus, sensory deprivation of one modality leads to serotonin release in remaining modalities, facilitates GluR1-dependent synaptic strengthening, and refines cortical organization.

    DOI: 10.1016/j.neuron.2011.01.016

    Web of Science

    PubMed

    researchmap

  • Fbxo45, a Novel Ubiquitin Ligase, Regulates Synaptic Activity Reviewed

    Hirobumi Tada, Hirotaka James Okano, Hiroshi Takagi, Shinsuke Shibata, Ikuko Yao, Masaki Matsumoto, Toru Saiga, Keiichi I. Nakayama, Haruo Kashima, Takuya Takahashi, Mitsutoshi Setou, Hideyuki Okano

    JOURNAL OF BIOLOGICAL CHEMISTRY   285 ( 6 )   3840 - 3849   2010.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Neurons communicate with each other through synapses. To establish the precise yet flexible connections that make up neural networks in the brain, continuous synaptic modulation is required. The ubiquitin-proteasome system of protein degradation is one of the critical mechanisms that underlie this process, playing crucial roles in the regulation of synaptic structure and function. We identified a novel ubiquitin ligase, Fbxo45, that functions at synapses. Fbxo45 is evolutionarily conserved and selectively expressed in the nervous system. We demonstrated that the knockdown of Fbxo45 in primary cultured hippocampal neurons resulted in a greater frequency of miniature excitatory postsynaptic currents. We also found that Fbxo45 induces the degradation of a synaptic vesicle-priming factor, Munc13-1. We propose that Fbxo45 plays an important role in the regulation of neurotransmission by modulating Munc13-1 at the synapse.

    DOI: 10.1074/jbc.M109.046284

    Web of Science

    PubMed

    researchmap

  • Acquisition mechanisms of hippocampal dependent spatial tasks are varied during the estrous cycle in rats Reviewed

    Toshiya Funabashi, Tatsuo Akema, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E283 - E284   2010

     More details

    Language:English   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1261

    Web of Science

    researchmap

  • The cAMP response element-binding protein in the bed nucleus of the stria terminalis modulates the formalin-induced pain behavior in the female rat Reviewed

    Hiroko Hagiwara, Maho Ishida, Jun Arita, Dai Mitsushima, Takuya Takahashi, Fukuko Kimura, Toshiya Funabashi

    EUROPEAN JOURNAL OF NEUROSCIENCE   30 ( 12 )   2379 - 2386   2009.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL PUBLISHING, INC  

    Differences in male and female responses to pain are widely recognized in many species, including humans, but the cerebral mechanisms that generate these responses are unknown. Using the formalin test, we confirmed that proestrus female rats showed nociceptive behavior, modulated by estrogen that was distinct from male rats, particularly during the interphase period. We then explored the brain areas, which were involved in the female pattern of nociceptive behavior. We found that, after a formalin injection and at the time corresponding to the behavioral interphase, the number of phosphorylated cAMP response element-binding protein (pCREB)-immunoreactive neurons observed by immunocytochemistry increased in the dorsolateral division of the bed nucleus of the stria terminalis (BSTLD) in female but not male rats. There were no significant sex differences in pCREB expression following formalin in any region other than the BSTLD. The increased pCREB in female rats was eliminated after an ovariectomy and restored with 17 beta-estradiol treatment. Neither an orchidectomy nor 17 beta-estradiol treatment affected the pCREB response in male rats. The increase in pCREB expression in the BSTLD in female rats after formalin injection was confirmed with immunoblotting. To determine the role of CREB in the BSTLD, adenovirus-mediated expression of a dominant-negative form of CREB (mCREB) was carried out. The nociceptive behavior during interphase was significantly attenuated by injection of virus carrying mCREB into the BSTLD in female rats but not in male rats. These results suggest a novel role for CREB in the BSTLD as a modulator of the pain response in a female-specific, estrogen-dependent manner.

    DOI: 10.1111/j.1460-9568.2009.07002.x

    Web of Science

    PubMed

    researchmap

  • Activational and Organisational Effects of Gonadal Steroids on Sex-Specific Acetylcholine Release in the Dorsal Hippocampus Reviewed

    D. Mitsushima, K. Takase, T. Takahashi, F. Kimura

    JOURNAL OF NEUROENDOCRINOLOGY   21 ( 4 )   400 - 405   2009.4

     More details

    Language:English   Publisher:WILEY-BLACKWELL PUBLISHING, INC  

    Acetylcholine (ACh) release in the dorsal hippocampus increases during stress, exploration or learning, exhibiting sex-specific 24-h release profile. We review the role of gonadal steroids on the ACh release in the dorsal hippocampus. In our studies, we found that male rats showed higher extracellular ACh levels than females, but gonadectomy decreased ACh levels in both sexes of rats and subsequently eliminated the sex difference. To examine the sex difference under comparable gonadal steroid levels, we implanted steroid capsules after gonadectomy. Oestradiol supplementation maintained circulating oestradiol to the levels in proestrous female rats, whereas testosterone capsules maintained circulating testosterone to the levels similar to intact male rats. Under comparable gonadal steroids levels, ACh levels were sex-specific. Testosterone replacement in orchidectomised rats clearly restored ACh levels, which were greater than ovariectomised testosterone-primed rats. Similarly, oestradiol replacement in ovariectomised rats successfully restored ACh levels, which were higher than orchidectomised oestradiol-primed rats. These results suggest sex-specific activational effects of gonadal steroids on ACh release. To further examine the organisational effect, female pups were neonatally treated with oil, testosterone, oestradiol, or dihydrotestosterone. These rats were bilaterally ovariectomised and a testosterone capsule was implanted at postnatal week 8. Neonatal treatment of either testosterone or oestradiol clearly increased ACh levels, whereas neonatal dihydrotestosterone treatment failed to change levels. These results suggest that: (i) gonadal steroids maintain the sex-specific ACh release in the dorsal hippocampus and (ii) neonatal activation of oestrogen receptors is sufficient to mediate masculinisation of the septo-hippocampal cholinergic system.

    DOI: 10.1111/j.1365-2826.2009.01848.x

    Web of Science

    PubMed

    researchmap

  • Activational and organisational effects of gonadal steroids on sex-specific acetylcholine release in the dorsal hippocampus.

    Mitsushima D, Takase K, Takahashi T, Kimura F

    Journal of neuroendocrinology   2009.3

     More details

    Publishing type:Research paper (scientific journal)  

    Acetylcholine (ACh) release in the dorsal hippocampus increases during stress, exploration or learning, exhibiting sex-specific 24-h release profile. We review the role of gonadal steroids on the ACh release in the dorsal hippocampus. In our studies, we found that male rats showed higher extracellular ACh levels than females, but gonadectomy decreased ACh levels in both sexes of rats and subsequently eliminated the sex difference. To examine the sex difference under comparable gonadal steroid levels, we implanted steroid capsules after gonadectomy. Oestradiol supplementation maintained circulating oestradiol to the levels in proestrous female rats, whereas testosterone capsules maintained circulating testosterone to the levels similar to intact male rats. Under comparable gonadal steroids levels, ACh levels were sex-specific. Testosterone replacement in orchidectomised rats clearly restored ACh levels, which were greater than ovariectomised testosterone-primed rats. Similarly, oestradiol replacement in ovariectomised rats successfully restored ACh levels, which were higher than orchidectomised oestradiol-primed rats. These results suggest sex-specific activational effects of gonadal steroids on ACh release. To further examine the organisational effect, female pups were neonatally treated with oil, testosterone, oestradiol, or dihydrotestosterone. These rats were bilaterally ovariectomised and a testosterone capsule was implanted at postnatal week 8. Neonatal treatment of either testosterone or oestradiol clearly increased ACh levels, whereas neonatal dihydrotestosterone treatment failed to change levels. These results suggest that: (i) gonadal steroids maintain the sex-specific ACh release in the dorsal hippocampus and (ii) neonatal activation of oestrogen receptors is sufficient to mediate masculinisation of the septo-hippocampal cholinergic system.

    DOI: 10.1111/j.1365-2826.2009.01848.x

    PubMed

    researchmap

  • Sex-specific 24-h profile of extracellular serotonin levels in the medial prefrontal cortex Reviewed

    Susumu Jitsuki, Fukuko Kimura, Toshiya Funabashi, Takuya Takahashi, Dai Mitsushima

    BRAIN RESEARCH   1260   30 - 37   2009.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    The medial prefrontal cortex (mPFC) controls emotional responses in many species, receiving serotonergic innervation from the dorsal and median raphe nucleus (DRN and MRN). To examine the sex difference in 24-h profiles of extracellular serotonin (5HT) levels in the mPFC, an in vivo microdialysis study was performed using intact male, diestrous female, and proestrous female rats. Dialysates were automatically collected by a microdialysis probe from the mPFC every 30 min for more than 24 h under freely moving conditions. The levels of 5HT in dialysates were quantified by high performance liquid chromatography. Extracellular 5HT levels exhibited episodic changes in the mPFC of both sexes of rats, with both diestrous and proestrous females exhibiting a clear diurnal change; the 5HT levels were high during the dark phase, but low during the light phase. In contrast, male rats exhibited relatively high 5HT levels throughout the day without significant diurnal changes. At mathematically analyzed trough, males showed higher 5HT levels than diestrous or proestrous females. The overall 24-h 5HT levels in males were significantly greater than proestrous females, but were not different from diestrous females. Further, stereological methods were used to examine the number of tryptophan hydroxylase (TrpH), but no sex differences in the number of TrpH immunoreactive cells in the DRN and MRN were observed. These results suggest that sex and/or the gonadal steroid environment may affect the 24-h profile of extracellular 5HT in the mPFC of rats without changes in the number of 5HT neurons in the DRN and MRN. (C) 2009 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.brainres.2008.12.084

    Web of Science

    PubMed

    researchmap

  • DOPA cyclohexyl ester, a DOPA antagonist, blocks the depressor responses elicited by microinjections of nicotine into the nucleus tractus solitarii of rats Reviewed

    Y. Murota, M. Fujii, Y. Sugiyama, T. Funabashi, T. Yagami, T. Takahashi, Y. Goshima

    NEUROSCIENCE LETTERS   442 ( 2 )   114 - 117   2008.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Nicotinic cholinergic receptors play a role in cardiovascular regulation in the lower brain stem. Herein, we present evidence that L-3,4-dihydroxyphenylatanine (DOPA), a putative neurotransmitter in the central nervous system, is involved in the depressor response to microinjection of nicotine into the nucleus tractus solitarii (NTS). Microinjection of nicotine into the medial area of the NTS led to decreases in arterial blood pressure and heart rate in anesthetized rats. Mecamylamine, a nicotinic receptor antagonist, microinjected into NTS, blocked the depressor and bradycardic responses to nicotine. Nicotine-induced depressor and bradycardic responses were blocked by DOPA cyclohexyl ester (DOPA CHE), an antagonist for DOPA. DOPA CHE did not modify the action of carbachol on excitatory postsynaptic potential in rat cortical slices. These results suggest that endogenous DOPA is involved in nicotine-induced depressor responses in the NTS of anesthetized rats. (c) 2008 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.neulet.2008.06.077

    Web of Science

    researchmap

  • Regulation of spine development by Semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1 Reviewed

    Naoya Yamashita, Asa Morita, Yutaka Uchida, Fumio Nakamura, Hiroshi Usui, Toshio Ohshima, Masahiko Taniguchi, Jerome Honnorat, Nicole Thomasset, Kohtaro Takei, Takuya Takahashi, Pappachan Kolattukudy, Yoshio Goshima

    JOURNAL OF NEUROSCIENCE   27 ( 46 )   12546 - 12554   2007.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SOC NEUROSCIENCE  

    Collapsin response mediator protein 1(CRMP1) is one of the CRMP family members that mediates signal transduction of axonal guidance and neuronal migration. We show here evidence that CRMP1 is involved in semaphorin3A (Sema3A)-induced spine development in the cerebral cortex. In the cultured cortical neurons from crmp1(+/-) mice, Sema3A increased the density of clusters of synapsin I and postsynaptic density-95, but this increase was markedly attenuated in crmp1(-/-) mice. This attenuation was also seen in cyclin-dependent kinase 5 (cdk5)(-/-) neurons. Furthermore, the introduction of wild-type CRMP1 but not CRMP1-T509A/S522A, (Thr 509 and Ser 522 were replaced by Ala), a mutant that cannot be phosphorylated by Cdk5, into crmp1(-/-) neurons rescued the defect in Sema3A responsiveness. The Golgi-impregnation method showed that the crmp1(-/-) layer V cortical neurons showed a lower density of synaptic bouton-like structures and that this phenotype had genetic interaction with sema3A. These findings suggest that Sema3A-induced spine development is regulated by phosphorylation of CRMP1 by Cdk5.

    DOI: 10.1523/JNEUROSCI.3463-07.2007

    Web of Science

    PubMed

    researchmap

  • Collapsin response mediator protein 1 mediates Reelin signaling in cortical neuronal migration Reviewed

    Naoya Yamashita, Yutaka Uchida, Toshio Ohshima, Syu-ichi Hirai, Fumio Nakamura, Masahiko Taniguchi, Katsuhiko Mikoshiba, Jerome Honnorat, Pappachan Kolattukudy, Nicole Thomasset, Kohtaro Takei, Takuya Takahashi, Yoshio Goshima

    JOURNAL OF NEUROSCIENCE   26 ( 51 )   13357 - 13362   2006.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SOC NEUROSCIENCE  

    Collapsin response mediator protein 1 ( CRMP1) is one of the CRMP family members that mediates signal transduction of axon guidance molecules. Here, we show evidence that CRMP1 is involved in Reelin ( Reln) signaling to regulate neuronal migration in the cerebral cortex. In crmp1(-/-) mice, radial migration of cortical neurons was retarded. This phenotype was not observed in the sema3A(-/-) and crmp1(+/+); sema3A(+/+) cortices. However, CRMP1 was colocalized with disabled- 1 ( Dab1), an adaptor protein in Reln signaling. In the Reln(rl/rl) cortex, CRMP1 and Dab1 were expressed at a higher level, yet tyrosine phosphorylated at a lower level. Loss of crmp1 in a dab1 heterozygous background led to the disruption of hippocampal lamination, a Reeler- like phenotype. In addition to axon guidance, CRMP1 regulates neuronal migration by mediating Reln signaling.

    DOI: 10.1523/JNEUROSCI.4276-06.2006

    Web of Science

    PubMed

    researchmap

  • Experience strengthening transmission by driving AMPA receptors into synapses Reviewed

    T Takahashi, K Svoboda, R Malinow

    SCIENCE   299 ( 5612 )   1585 - 1588   2003.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC ADVANCEMENT SCIENCE  

    The mechanisms underlying experience-dependent plasticity in the brain may depend on the AMPA subclass of glutamate receptors (AMPA-Rs). We examined the trafficking of AMPA-Rs into synapses in the developing rat barrel cortex. In vivo gene delivery was combined with in vitro recordings to show that experience drives recombinant GluR1, an AMPA-R subunit, into synapses formed between layer 4 and layer 2/3 neurons. Moreover, expression of the GluR1 cytoplasmic tail, a construct that inhibits synaptic delivery of endogenous AMPA-Rs during long-term potentiation, blocked experience-driven synaptic potentiation. In general, synaptic incorporation of AMPA-Rs in vivo conforms to rules identified in vitro and contributes to plasticity driven by natural stimuli in the mammalian brain.

    DOI: 10.1126/science.1079886

    Web of Science

    PubMed

    researchmap

  • PlexinA1 autoinhibition by the Plexin Sema domain Reviewed

    T Takahashi, SM Strittmatter

    NEURON   29 ( 2 )   429 - 439   2001.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Semaphorin 3A (Sema3A) binds to neuropilin-1 (NP1) and activates the transmembrane Plexin to transduce a repulsive axon guidance signal. Here, we show that Sema3 signals are transduced equally effectively by PlexinA1 or PlexinA2, but not by PlexinA3. Deletion analysis of the PlexinA1 ectodomain demonstrates that the sema domain prevents PlexinA1 activation in the basal state. Sema-deleted PlexinA1 is constitutively active, producing cell contraction, growth cone collapse, and inhibition of neurite outgrowth. The sema domain of PlexinA1 physically associates with the remainder of the PlexinA1 ectodomain and can reverse constitutive activation. Both the sema portion and the remainder of the ectodomain of PlexinA1 associate with NP1 in a Sema3A-independent fashion. Plexin Al is autoinhibited by its sema domain, and Sema3A/NP1 releases this inhibition.

    DOI: 10.1016/S0896-6273(01)00216-1

    Web of Science

    PubMed

    researchmap

  • Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors Reviewed

    T Takahashi, A Fournier, F Nakamura, LH Wang, Y Murakami, RG Kalb, H Fujisawa, SM Strittmatter

    CELL   99 ( 1 )   59 - 69   1999.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Class 1 and 3 semaphorins repulse axons but bind to different cell surface proteins. We find that the two known semaphorin-binding proteins, plexin 1 (Plex 1) and neuropilin-1 (NP-1), form a stable complex. Plex 1 alone does not bind semaphorin-3A (Sema3A), but the NP-1/Plex 1 complex has a higher affinity for Sema3A than does NP-1 alone. While Sema3A binding to NP-1 does not alter nonneuronal cell morphology, Sema3A interaction with NP-1/Plex 1 complexes induces adherent cells to round up. Expression of a dominant-negative Plex 1 in sensory neurons blocks Sema3A-induced growth cone collapse. Sema3A treatment leads to the redistribution of growth cone NP-1 and plexin into clusters. Thus, physiologic Sema3A receptors consist of NP-1/plexin complexes.

    DOI: 10.1016/S0092-8674(00)80062-8

    Web of Science

    PubMed

    researchmap

  • Growth cone neuropilin-1 mediates collapsin-1/Sema III facilitation of antero- and retrograde axoplasmic transport Reviewed

    Y Goshima, H Hori, Y Sasaki, T Yang, M Kagoshima-Maezono, CX Li, T Takenaka, F Nakamura, T Takahashi, SM Strittmatter, Y Misu, T Kawakami

    JOURNAL OF NEUROBIOLOGY   39 ( 4 )   579 - 589   1999.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JOHN WILEY & SONS INC  

    Collapsin-1/Sema III, a member of the semaphorin family, has been implicated in axonal path-finding as a repulsive guidance cue. Cellular and molecular mechanisms by which collapsin-1 exerts its action are not fully understood. Collapsin-1 induces growth cone collapse via a pathway which may include neuropilin-1, a cell-surface collapsin-1 binding protein, as well as intracellular CRMP-62 and heterotrimeric G proteins. We previously identified a second action of collapsin-1, the facilitation of antero- and retrograde axoplasmic transport. This response occurs via a mechanism distinct from that causing growth cone collapse. To investigate the possible involvement of neuropilin-1 in the action of collapsin-1 on axoplasmic transport, we produced a soluble neuropilin-1 (sNP-1) lacking the transmembrane and intracellular region. sNP-1 progressively displaced the dose-response curve for collapsin-1 eo induce growth cone collapse to higher concentrations, sNP-1 also inhibited collapsin-1-induced augmentation of both antero- and retrograde axoplasmic transport. Furthermore, an anti-neuropilin-1 antibody blocked the collapsin-induced axoplasmic transport. These results together indicate that neuropilin-1 mediates collapsin-1 action on axoplasmic transport. To visualize collapsin-1 binding to endogenous neuropilin-1, we used a truncated collapsin-1-alkaline phosphatase fusion protein (CAP-4). CAP-4 stains the growth cone, neurite, and cell body. However, local application of collapsin-1 to growth cone but to neither neurite nor cell body promotes axoplasmic transport. Thus, growth cone NP-1 mediates the facilitatory action of collapsin-1 on antero- and retrograde axoplasmic transport, (C) 1999 John Wiley & Sons. Inc.

    DOI: 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9

    Web of Science

    researchmap

  • Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse Reviewed

    F Nakamura, M Tanaka, T Takahashi, RG Kalb, SM Strittmatter

    NEURON   21 ( 5 )   1093 - 1100   1998.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Somatosensory axon outgrowth is repulsed when soluble semaphorin D (semD) binds to growth cone neuropilin-1 (Npn-1). Here, semD ligand binding studies of Npn-1 mutants demonstrate that the sema domain binds to the amino-terminal quarter, or complement-binding (CUB) domain, of Npn-1. By herpes simplex virus- (HSV-) mediated expression of Npn-1 mutants in chick retinal ganglion cells, we show that semD-induced growth cone collapse requires two segments of the ectodomain of Npn-1, the CUB domain and the juxtamembrane portion, or MAM (meprin, A5, mu) domain. In contrast, the transmembrane segment and cytoplasmic tail of Npn-1 are not required for biologic activity. These data imply that the CUB and MAM ectodomains of Npn-1 interact with another transmembrane growth cone protein that in turn transduces a semD signal into axon repulsion.

    DOI: 10.1016/S0896-6273(00)80626-1

    Web of Science

    PubMed

    researchmap

  • Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors Reviewed

    T Takahashi, F Nakamura, Z Jin, RG Kalb, SM Strittmatter

    NATURE NEUROSCIENCE   1 ( 6 )   487 - 493   1998.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE AMERICA INC  

    Neuropilin-1 (NP-1) has been identified as a necessary component of a semaphorin D (SemD) receptor; that repulses dorsal root ganglion (DRG) axons during development. SemA and SemE are related to SemD and bind to NP-1, but do not repulse DRG axons. By expressing NP-1 in retinal neurons and NP-2 in DRG neurons, we demonstrate that neuropilins are sufficient to determine the functional specificity of semaphorin responsiveness. SemA and SemE block SemD binding to NP-1 and abolish SemD repulsion in axons expressing NP-1. SemA and SemE seem to have a newly discovered protein antagonist capacity at NP-1 receptors, whereas they act as agonists at receptors containing NP-2.

    Web of Science

    researchmap

  • Neuronal and non-neuronal collapsin-1 binding sites in developing chick are distinct from other semaphorin binding sites Reviewed

    T Takahashi, F Nakamura, SM Strittmatter

    JOURNAL OF NEUROSCIENCE   17 ( 23 )   9183 - 9193   1997.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SOC NEUROSCIENCE  

    The collapsin and semaphorin family of extracellular proteins contributes to axonal path finding by repulsing axons and collapsing growth cones. To explore the mechanism of collapsin-1 action, we expressed and purified a truncated collapsin-1-alkaline phosphatase fusion protein (CAP-4). This protein retains biological activity as a DRG growth cone collapsing agent and saturably binds to DRG neurons with low nanomolar affinity. Specific CAP-4 binding sites are present on DRG neurons, sympathetic neurons, and motoneurons, but not on retinal, cortical, or brainstem neurons. Outside the nervous system, high levels of CAP-4 binding sites are present in the mesenchyme surrounding major blood vessels and developing bone and in lung. These sites provide a substrate for the collapsin-1-dependent patterning of non-neuronal tissues perturbed in sema III (-/-) mice. The staining patterns for mouse semaphorin D/III and chick collapsin-1 fusion proteins are indistinguishable from one another but quite separate from that for semaphorin B and M-semaphorin F fusion proteins. These data imply that a family of high-affinity semaphorin binding sites similar in complexity to the semaphorin ligand family exists.

    Web of Science

    researchmap

  • CLONING OF A DROSOPHILA-MELANOGASTER HOMOLOG OF THE MOUSE TYPE-I BONE MORPHOGENETIC PROTEINS-2/-4 RECEPTOR - A POTENTIAL DECAPENTAPLEGIC RECEPTOR Reviewed

    H OKANO, S YOSHIKAWA, A SUZUKI, N UENO, M KAIZU, M OKABE, T TAKAHASHI, M MATSUMOTO, K SAWAMOTO, K MIKOSHIBA

    GENE   148 ( 2 )   203 - 209   1994.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    The Drosophila melanogaster (Dot) decapentaplegic (dpp) gene product plays an essential role during several stages of Dm development. The DPP protein is a member of the transforming growth factor-beta (TGF-beta) superfamily and an orthologue of mammalian bone morphogenetic proteins (BMP-2 and -4). Recently, a cDNA clone encoding the mouse Ser/Thr kinase receptor specific for BMP-2/-4 (mTFR11) was isolated. Here, we describe the deduced primary structure, the cytogenetic position and expression pattern of the Dm homologue of mTFR11 (DTFR), a putative DPP receptor. The cytogenetic position of the Dm dtfr gene was mapped to 25D. DTFR has striking homology to mTFR11, especially in the cytoplasmic domain (approx. 63%), including a Ser + Gly-rich box that is characteristic of type-I receptors for the TGF-P superfamily. Although the amino acid (aa) sequence of the extracellular domain is less conserved than that of the cytoplasmic domain, the extracellular domains of these two molecules were more homologous (approx. 27%) to each other than any other receptors for the TGF-beta superfamily. The spacing of Cys residues in the extracellular domain, which is considered crucial to ligand specificity, is highly conserved in these two receptors. During Dm embryonic development, its expression pattern changes in a dynamic fashion with high levels of expression in mesoderm and midgut, with some relation to dpp mutant phenotypes.

    DOI: 10.1016/0378-1119(94)90690-4

    Web of Science

    PubMed

    researchmap

  • The development of Drosophila melanogaster

    高橋琢哉, 岡野栄之

    Brain Medical   6   119 - 126   1994

     More details

  • EVIDENCE FOR EROSION OF MOUSE CPG ISLANDS DURING MAMMALIAN EVOLUTION Reviewed

    K MATSUO, O CLAY, T TAKAHASHI, J SILKE, W SCHAFFNER

    SOMATIC CELL AND MOLECULAR GENETICS   19 ( 6 )   543 - 555   1993.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PLENUM PUBL CORP  

    In housekeeping and many tissue-specific genes, the promoter is embedded in a so-called CpG island. We have compared the available human and mouse DNA sequences with respect to their CpG island properties. While mouse sequences showed a simple gradient distribution of G + C content and CpG densities, man had a distinct peak of sequences with typical CpG island characteristics. Pairwise comparison of 23 orthologous genes revealed that mouse almost always had a less pronounced CpG island than man, or none at all. In both species the requirements for a functional CpG island may be similar in that most DNA regions with a density of six or more CpG per 100 bp remain unmethylated. However, the mouse has apparently experienced more accidental CpG island methylation, suggested by local TpG and CpA excess. We propose that: (1) in mouse the CpG islands do not represent the ancestral state but have been eroded during evolution, and (2) this erosion may be related to the mouse's small body mass and short life-span, allowing for a more relaxed control of gene activity.

    DOI: 10.1007/BF01233381

    Web of Science

    PubMed

    researchmap

▼display all

MISC

  • 【シナプス】シナプス伝達 AMPA受容体を中核としたtranslational medicine

    高橋 琢哉

    生体の科学   74 ( 1 )   41 - 46   2023.2

     More details

    Language:Japanese   Publisher:(公財)金原一郎記念医学医療振興財団  

    <文献概要>1つの神経から異なる神経に情報伝達が起こるときに,その伝達を仲介する構造体がシナプスである。興奮性グルタミン酸シナプスは,脳内情報伝達において最も中核的役割を果たしている。シナプス前末端に興奮が伝導すると,シナプス小胞からグルタミン酸がエクソサイトーシスにより放出され,シナプス後膜に存在するグルタミン酸受容体に結合する。AMPA(α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)受容体はそれ自体がイオンチャネルを構成するグルタミン酸受容体であり,グルタミン酸シナプスにおいて非常に重要な役割を果たしている。AMPA受容体は通常4量体のイオンチャネルを形成しており,グルタミン酸が結合するとイオンチャネルが開き陽イオンが透過できるようになる。細胞が興奮していない静止膜電位の状態であると,グルタミン酸が結合して活性化したAMPA受容体を介して陽イオンが細胞内に流入し,シナプス後膜の電位が上昇し(脱分極し),興奮性にシフトする。これまでの動物実験を中心とした基礎研究の蓄積により,AMPA受容体が多様な神経機能を中心的に担っていることが明らかになっている。本稿では,AMPA受容体を基盤としたヒト生体脳の研究,治療法,診断法の可能性について概説する。

    CiNii Books

    CiNii Research

    researchmap

  • 知っておきたい神経科学のキィワード AMPA受容体を起点としたシナプス生理学のtranslational medicine

    高橋 琢哉

    Journal of Clinical Rehabilitation   31 ( 14 )   1424 - 1429   2022.12

     More details

    Language:Japanese   Publisher:医歯薬出版(株)  

    CiNii Books

    CiNii Research

    researchmap

  • AMPA受容体をターゲットとした革新的医療創生

    高橋 琢哉

    日本頭痛学会誌   49 ( 1 )   8 - 13   2022.9

  • 目でみるてんかん AMPA受容体標識PETプローブによるてんかん病態解明

    高橋 琢哉

    Epilepsy: てんかんの総合学術誌   16 ( 1 )   6 - 9   2022.6

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    researchmap

  • シナプス生理学のトランスレーショナルメディシン

    高橋 琢哉

    The Japanese Journal of Rehabilitation Medicine   ( 特別号 )   S248 - S248   2022.5

     More details

    Language:Japanese   Publisher:(公社)日本リハビリテーション医学会  

    researchmap

  • Visualization of AMPA receptors in epilepsy.

    宮崎智之, 阿部弘基, 高橋琢哉

    月刊脳神経内科   96 ( 5 )   578 - 582   2022.5

     More details

  • シナプス生理学のtranslational medicine

    高橋 琢哉

    ブレインサイエンス・レビュー   2022   41 - 60   2022.4

     More details

    Language:Japanese   Publisher:(株)アドスリー  

    researchmap

  • シナプス機能最重要分子AMPA受容体のヒト生体脳における可視化・定量化

    高橋 琢哉

    細胞   54 ( 2 )   61 - 64   2022.2

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    精神神経疾患には難治性にものも多く、創薬を含めたその診断・治療法開発のためには強固な科学的根拠が必要である。グルタミン酸シナプスは脳内の興奮性シナプスの大半を占めると言われている。グルタミン酸に結合し、情報伝達を担うグルタミン酸受容体は何種類か存在する。その中でもAMPA受容体(α-Amino-3-hydroxy-5-Methyl-4-isoxazolepropionic Acid Receptor)はグルタミン酸シナプス伝達において特に重要な役割を担っている。AMPA受容体は脳内情報伝達の最重要分子であり、その機能の破綻は多くの精神神経疾患に関わっているということが実験動物を用いた基礎研究において示唆されているが、臨床応用に結びついている例は稀有である。その大きな要因は、ヒト生体脳でAMPA受容体を可視化・定量化する技術が存在していないため、ヒト疾患におけるAMPA受容体の役割が不明であったからである。筆者らは最近、ヒト生体でAMPA受容体を可視化・定量化する世界初の技術となるポジトロン断層撮影(PET)用プローブ、[11C]K-2の開発に成功した。(著者抄録)

    researchmap

  • 脳損傷後のリハビリテーション効果促進薬の開発

    中島 和希, 高橋 琢哉

    細胞   54 ( 2 )   99 - 102   2022.2

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    脳卒中は運動麻痺や高次脳機能障害などを特徴とする脳血管障害である。脳卒中により生じた運転麻痺は元の水準までの運動機能回復は困難である。運動機能回復を促進する治療戦略が考案されているが、臨床現場への還元は未だ障壁が高い現状にある。より効果的な治療法の発展には、脳損傷後のリハビリテーションによる運動機能回復が促進されるメカニズムの理解に基づいた治療薬の開発が必須と考える。筆者らは、マウス一次運動野損傷モデル及び霊長類内包出血モデルを用いて、AMPA(α-3-hydroxy-5-methyl-4-isoxazole propionic acid)受容体のシナプス移行を促進することで運動機能回復を促進する新規化合物Edonerpic maleate(T-817MA; 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}azetidin-3-ol maleate)の開発に成功した。(著者抄録)

    researchmap

  • シナプス生理学のtranslational medicine

    高橋 琢哉

    日本頭痛学会誌   48 ( 2 )   298 - 298   2021.11

     More details

    Language:Japanese   Publisher:(一社)日本頭痛学会  

    researchmap

  • シナプス生理学のトランスレーショナルアプローチ

    高橋 琢哉

    精神神経学雑誌   ( 2021特別号 )   S236 - S236   2021.9

     More details

    Language:Japanese   Publisher:(公社)日本精神神経学会  

    researchmap

  • 「治療抵抗性うつ病に対するケタミン作用機序の探索 AMPA受容体PET研究」の研究プロトコールの紹介

    内田 裕之, 大谷 洋平, 谷 英明, 三村 將, 宮崎 智之, 高橋 琢哉

    日本うつ病学会総会・日本認知療法・認知行動療法学会プログラム・抄録集   18回・21回   373 - 373   2021.7

     More details

    Language:Japanese   Publisher:日本うつ病学会・日本認知療法・認知行動療法学会  

    researchmap

  • Clinical Topics 機能性疾患 AMPA受容体PETの可能性

    阿部 弘基, 高橋 琢哉

    Annual Review神経   2021   344 - 353   2021.6

     More details

    Language:Japanese   Publisher:(株)中外医学社  

    researchmap

  • 【脳卒中運動麻痺へのアプローチ】リハビリテーション治療効果を促進する低分子化合物edonerpic maleateによる運動麻痺へのアプローチ

    阿部 弘基, 高橋 琢哉

    Journal of Clinical Rehabilitation   30 ( 6 )   589 - 595   2021.6

     More details

    Language:Japanese   Publisher:医歯薬出版(株)  

    researchmap

  • 当院における膿瘍形成性虫垂炎に対する治療法の検討

    高橋 琢哉, 北島 政幸, 中谷 晃典, 永易 希一, 柵山 尚紀, 岸根 健二, 佐藤 剛, 牧野 有里香, 池上 満智彰, 田中 正史

    日本臨床外科学会雑誌   82 ( 4 )   811 - 811   2021.4

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • Development of new compound that facilitate motor function recovery after brain injury

    Nakajima Waki, Takahashi Takuya

    JAPANESE JOURNAL OF PHYSICAL THERAPY FUNDAMENTALS   23 ( 1 )   37 - 45   2021.3

     More details

    Language:Japanese   Publisher:Japanese Association of Physical Therapy Fundamentals  

    The central nervous system injury such as stroke can severely cause the motor paralysis. Although the approach of the rehabilitative training is developed, many patients still face the restrictions in their daily living after rehabilitation. Thereby, a new compound with strong potential to enhance motor function recovery with rehabilitation is an unmet medical needs. We focus on the one of glutamate receptors, AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, which plays an important role in learning and memory. Here, we found a novel small low molecular compound, edonerpic-maleic acid edonerpic MA), facilitated experience-dependent synaptic AMPA receptor delivery in barrel cortex and dramatically accelerated motor function recovery after brain damage in rodent model. Furthermore, edonerpic MA enhanced the upper limb function recovery of macaque monkeys with the internal capsule hemorrhage. Currently, a phase 2 clinical trial is being conducted to verify the efficacy of edonerpic MA in stroke patients and has attracted global attention.

    DOI: 10.24780/jptf.23.1_37

    CiNii Research

    researchmap

    Other Link: https://search-tp.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2021&ichushi_jid=J05805&link_issn=&doc_id=20210319280006&doc_link_id=%2Fch1thrpy%2F2020%2F002301%2F006%2F0037-0045%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fch1thrpy%2F2020%2F002301%2F006%2F0037-0045%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 精神疾患の病理病態解析~認知症との関係を探る シナプス可塑性のトランスレーショナルリサーチ

    高橋 琢哉

    Dementia Japan   34 ( 4 )   461 - 461   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本認知症学会  

    researchmap

  • ニューロサイエンスの最新情報 シナプス可塑性のトランスレーショナルリサーチ

    高橋 琢哉

    Clinical Neuroscience   38 ( 10 )   1320 - 1322   2020.10

     More details

    Language:Japanese   Publisher:(株)中外医学社  

    researchmap

  • 神経疾患の「機能回復ネットワーク」の探索

    阿部 弘基, 高橋 琢哉

    Medical Science Digest   46 ( 10 )   634 - 637   2020.9

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    根本的治療法が存在しない神経疾患では機能障害の後遺は避け難い。機能障害を改善・代償するには疾患の進行や再発を抑制する治療に加えて、リハビリテーションが重要である。近年、脳卒中に限らず、脊髄小脳変性症、パーキンソン病、多発性硬化症といった慢性進行性疾患でもリハビリテーション法の改良が試みられている。脳神経科学ではリハビリテーションによる機能回復は非障害脳領域における機能的再構築に依拠するとされてきたが、ヒト生体脳において疾患毎の機能回復能の神経生理学的理解は不十分である。我々は、急性脳損傷モデルにおいて、グルタミン酸AMPA受容体のシナプス後膜への移行促進がリハビリテーションによる運動機能回復を促進することを薬理学的に示した。現在はこの研究に動機づけられ、PET画像で得られるAMPA受容体発現密度分布を手掛かりとして、リハビリテーションを可能とする「機能回復ネットワーク」の疾患横断的解明に取り組んでいる。(著者抄録)

    researchmap

  • シナプス可塑性 基礎から臨床へ

    高橋 琢哉

    脳と発達   52 ( Suppl. )   S199 - S199   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本小児神経学会  

    researchmap

  • 【最新てんかん診療】AMPA受容体標識PETプローブによるてんかん病態解明

    高橋 琢哉

    クリニシアン   67 ( 5-6 )   516 - 523   2020.6

     More details

    Language:Japanese   Publisher:エーザイ(株)  

    researchmap

  • 【てんかんの進歩】AMPA受容体のトランスレーショナルリサーチ

    高橋 琢哉

    Medical Science Digest   46 ( 2 )   84 - 87   2020.2

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    シナプスは神経細胞同士をつないでいる構造体である。シナプス前神経に興奮が伝わると、神経伝達物質がシナプス終末から放出され、受け手の神経のシナプス後膜にある受容体に結合する。そしてイオンチャネルを形成している受容体が開き、イオンが細胞内に流入してくる。興奮性グルタミン酸シナプスは脳内シナプスの大半を占めると言われており、グルタミン酸受容体の一つがAMPA受容体(α-Amino-3-hydroxy-5-Methyl-4-isoxazolepropionic Acid Receptor)である。本稿ではAMPA受容体を切り口としたシナプス研究の概念をヒト疾患の病態解明・革新的診断・治療法開発へと繋げていく挑戦について概説する。(著者抄録)

    researchmap

  • 【令和新時代の医療トピックス】AMPA受容体を切り口とした創薬

    高橋 琢哉

    クリニシアン   67 ( 1 )   7 - 12   2020.1

     More details

    Language:Japanese   Publisher:エーザイ(株)  

    researchmap

  • 精神神経疾患、特にてんかんとAMPA受容体

    高橋 琢哉

    Epilepsy: てんかんの総合学術誌   13 ( 2 )   81 - 86   2019.11

  • Doctor Interview : AMPA受容体から精神神経疾患の克服を目指す 高橋琢哉先生 横浜市立大学大学院医学研究科生理学教授

    高橋 琢哉

    精神科臨床legato / 「精神科臨床legato」編集委員会 編   5 ( 3 )   160 - 163   2019.11

     More details

    Language:Japanese   Publisher:メディカルレビュー社  

    CiNii Books

    CiNii Research

    researchmap

  • 11C標識新規トレーサーによるAMPA受容体の定量画像化のための臨床プロトコル

    木村 裕一, 山田 誉大, 波多野 真衣, 中島 和希, 宮崎 智之, 高橋 琢哉

    核医学   56 ( Suppl. )   S162 - S162   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本核医学会  

    researchmap

  • 創薬と神経画像研究 シナプス可塑性 基礎から臨床へ

    高橋 琢哉

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   29回・49回   218 - 218   2019.10

     More details

    Language:Japanese   Publisher:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • Novel findings from Bench to Bedside~リハビリテーション医学における神経可塑性研究の最前線 シナプス可塑性 基礎研究から臨床実装へ

    高橋 琢哉

    The Japanese Journal of Rehabilitation Medicine   56 ( 特別号 )   S375 - S375   2019.5

     More details

    Language:Japanese   Publisher:(公社)日本リハビリテーション医学会  

    researchmap

  • 分子細胞生物学に基づいたリハビリテーション医学

    高橋 琢哉

    The Japanese Journal of Rehabilitation Medicine   56 ( 特別号 )   S319 - S319   2019.5

     More details

    Language:Japanese   Publisher:(公社)日本リハビリテーション医学会  

    researchmap

  • シナプス可塑性 基礎から臨床へ

    高橋 琢哉

    日本臨床分子医学会学術総会プログラム・抄録集   56回   36 - 36   2019.4

     More details

    Language:Japanese   Publisher:日本臨床分子医学会  

    researchmap

  • リハビリテーション医学 脳卒中後リハビリテーションを促進する新規低分子化合物

    阿部 弘基, 高橋 琢哉

    医学のあゆみ   268 ( 7 )   585 - 586   2019.2

  • シナプス可塑性 基礎から臨床へ

    高橋 琢哉

    日本臨床精神神経薬理学会・日本神経精神薬理学会合同年会プログラム・抄録集   28回・48回   91 - 91   2018.11

     More details

    Language:Japanese   Publisher:日本臨床精神神経薬理学会・日本神経精神薬理学会  

    researchmap

  • 11C標識新規トレーサーによるLoganグラフィカル法を用いたAMPA受容体の定量画像化

    木村 裕一, 宮崎 智之, 高橋 琢哉

    核医学   55 ( Suppl. )   S167 - S167   2018.11

     More details

    Language:Japanese   Publisher:(一社)日本核医学会  

    researchmap

  • 精神科領域の用語解説 AMPA受容体

    阿部 弘基, 高橋 琢哉

    分子精神医学   18 ( 3 )   162 - 163   2018.7

     More details

    Language:Japanese   Publisher:(株)先端医学社  

    researchmap

  • 分子細胞生物学に基づいたリハビリテーション医学

    高橋 琢哉

    The Japanese Journal of Rehabilitation Medicine   55 ( 特別号 )   S189 - S189   2018.5

     More details

    Language:Japanese   Publisher:(公社)日本リハビリテーション医学会  

    researchmap

  • 複合体特異的なAMPA受容体光不活化技術の開発と海馬記録の解析

    竹本 研, 高橋 琢哉

    生命科学系学会合同年次大会   2017年度   [4LT08 - 1193)]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    researchmap

  • AMPA、mTOR基礎から臨床(New trend of epilepsy from basic to clinical:mTOR pathway and AMPA) 新規AMPA受容体PETイメージング製剤によるてんかん患者脳イメージング(New trend of epilepsy from basic to clinical: mTOR pathway and AMPA Imaging epileptic patients with novel PET probe for AMPA receptors)

    高橋 琢哉

    てんかん研究   35 ( 2 )   357 - 358   2017.9

     More details

    Language:English   Publisher:(一社)日本てんかん学会  

    researchmap

  • 霊長類内包出血後の機能回復を促進する新規薬剤の開発

    中島 和希, 阿部 弘基, 村田 弓, 奥田 智博, 肥後 範行, 高橋 琢哉

    理学療法学   44 ( Suppl.2 )   P - 2   2017.4

     More details

    Language:Japanese   Publisher:(一社)日本理学療法学会連合  

    researchmap

  • 精神神経疾患におけるAMPA受容体の役割 : ペランパネルの基礎と可能性

    タカハシ タクヤ

    30 ( 2 )   170 - 175   2017.2

     More details

  • 記憶―その瞬間に脳で何が起きているのか?AMPA受容体シナプス移行と行動

    高橋琢哉

    実験医学   34 ( 11 )   1726‐1729   2016.7

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 【記憶 その瞬間に脳で何が起きているのか?記憶を形成し、維持し、呼び起こすメカニズム】 AMPA受容体シナプス移行と行動

    高橋 琢哉

    実験医学   34 ( 11 )   1726 - 1729   2016.7

     More details

    Language:Japanese   Publisher:(株)羊土社  

    グルタミン酸作動性シナプスは脳内興奮性シナプスの約9割を占める。AMPA型グルタミン酸受容体(AMPA受容体)はグルタミン酸受容体の1つであり、神経活動の「実行部隊」ともいえる中心的な仲介役である。脳が外界からの刺激を受けて変化する「可塑性」の分子細胞基盤として「AMPA受容体のシナプスへの移行」があるが、本総説ではこの「AMPA受容体のシナプス移行」とさまざまな行動、環境との関係について概説する。(著者抄録)

    researchmap

  • Fear conditioning induced by interpersonal conflicts in patients with dysthymic disorder

    Mitsuhiro Tada, Aki Endo, Mika Konishi, Takaki Maeda, Masuru Mimura, Ai Otani, Takuya Takahashi, Yuri Terasawa, Hiroyuki Uchida, Satoshi Umeda

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   19   124 - 124   2016.6

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • Discovery of the novel drug to accelerate the training–dependent recovery of motor function after brain injury

    Takahashi Takuya

    Neurological Therapeutics   33 ( 3 )   394 - 394   2016.5

  • Stress and cognitive functions

    多田 敬典, 高橋 琢哉

    生体の科学   67 ( 1 )   47 - 50   2016.1

     More details

    Language:Japanese   Publisher:金原一郎記念医学医療振興財団 ; 1949-  

    DOI: 10.11477/mf.2425200397

    CiNii Books

    researchmap

  • トレーニング依存的に作用する脳卒中後のリハビリテーション効果促進薬の開発

    高橋琢哉

    神経治療学   32 ( 5 )   690   2015.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 脳損傷周辺領域に可塑的変化を誘導しリハビリテーション効果を促進する低分子化合物の同定

    阿部弘基, 阿部弘基, 実木亨, 小森隆司, 荒若菜, 水口愛香, 佐野亜加根, 須山紅美子, 奥田智博, 田中章景, 高橋琢哉

    神経治療学   32 ( 5 )   832 - 832   2015.9

     More details

    Language:Japanese   Publisher:日本神経治療学会  

    J-GLOBAL

    researchmap

  • 脳卒中治療の最前線 トレーニング依存的に作用する脳卒中後のリハビリテーション効果促進薬の開発

    高橋 琢哉

    神経治療学   32 ( 5 )   690 - 690   2015.9

     More details

    Language:Japanese   Publisher:日本神経治療学会  

    researchmap

  • From the Bench Bedsideを見据えた脳発達基礎医科学の新展開 シナプス可塑性 基礎研究から臨床応用へ

    高橋 琢哉

    脳と発達   47 ( Suppl. )   S146 - S146   2015.5

     More details

    Language:Japanese   Publisher:(一社)日本小児神経学会  

    researchmap

  • 社会脳―Social Brain 神経科学―マウスを使った分子基盤研究 精神疾患とシナプス可塑性

    高橋琢哉

    Clin Neurosci   33 ( 2 )   182 - 184   2015.2

     More details

    Language:Japanese   Publisher:(株)中外医学社  

    J-GLOBAL

    researchmap

  • Disrupted cortical function underlies behavior dysfunction due to social isolation (vol 122, pg 2690, 2012)

    Tomoyuki Miyazaki, Kenkichi Takase, Waki Nakajima, Hirobumi Tada, Daisuke Ohya, Akane Sano, Takahisa Goto, Hajime Hirase, Roberto Malinow, Takuya Takahashi

    JOURNAL OF CLINICAL INVESTIGATION   124 ( 6 )   2807 - 2807   2014.6

     More details

    Language:English   Publisher:AMER SOC CLINICAL INVESTIGATION INC  

    DOI: 10.1172/JCI76901

    Web of Science

    researchmap

  • AMPA受容体トラフィック研究の新展開 環境によって制御される経験依存的AMPA受容体シナプス移行

    高橋 琢哉

    日本生理学雑誌   76 ( 1 )   2 - 3   2014.1

     More details

    Language:Japanese   Publisher:(一社)日本生理学会  

    researchmap

  • シナプスリモデリングのメカニズムと生理的意義 海馬学習は興奮性と抑制性のシナプス伝達を強化する

    美津島 大, 高橋 琢哉

    日本生理学雑誌   76 ( 1 )   24 - 25   2014.1

     More details

    Language:Japanese   Publisher:(一社)日本生理学会  

    researchmap

  • シナプスリモデリングのメカニズムと生理的意義 大脳皮質回路の異種感覚間可塑性

    実木 亨, 高橋 琢哉

    日本生理学雑誌   76 ( 1 )   25 - 25   2014.1

     More details

    Language:Japanese   Publisher:(一社)日本生理学会  

    researchmap

  • B-53 マーモセットにおける経験依存的AMPA 受容体シナプス移行の観察

    高橋 琢哉, 実木 亨, 多田 敬典, 宮崎 智之

    霊長類研究所年報   43   107 - 107   2013.11

     More details

    Language:Japanese   Publisher:京都大学霊長類研究所  

    CiNii Books

    researchmap

  • 視覚剥奪ラットの体性感覚野における側方抑制の強化

    中島和希, 實木亨, 高橋琢哉

    日本理学療法学術大会(Web)   40 ( 大会特別号3 )   P - 021   2013.5

     More details

    Language:Japanese   Publisher:(公社)日本理学療法士協会  

    DOI: 10.14900/cjpt.2012.0.48100735.0

    J-GLOBAL

    researchmap

  • Hippocampal learning activates both excitatory and inhibitory synaptic transmission in CA1 neurons

    Dai Mitsushima, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   63   S107 - S107   2013

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER JAPAN KK  

    Web of Science

    researchmap

  • Neonatal chronic stress alters actin dynamics and experience-driven synaptic plasticity via ADF/cofilin inactivation in the rat barrel cortex

    Hirobumi Tada, Kumiko Suyama, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   63   S24 - S24   2013

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER JAPAN KK  

    Web of Science

    researchmap

  • Light induced inactivation of AMPA receptors toward an artificial memory erasure

    Kiwamu Takemoto, Takeharu Nagai, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   63   S24 - S24   2013

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER JAPAN KK  

    Web of Science

    researchmap

  • 最近の話題 視覚剥奪動物における体性感覚向上の分子細胞メカニズム

    高橋 琢哉

    日本薬理学雑誌   140 ( 2 )   97 - 97   2012.8

     More details

    Language:Japanese   Publisher:(公社)日本薬理学会  

    CiNii Books

    researchmap

  • 海馬依存的学習の分子細胞メカニズム

    高橋琢哉

    第一三共生命科学研究振興財団研究報告集   27   92 - 98   2011.11

     More details

  • Mechanisms underlying contextual fear learning. Reviewed

    Takahashi T

    Communicative & integrative biology   4   726 - 727   2011.11

     More details

    Publisher:6  

    PubMed

    researchmap

  • Light induced loss of function technology for AMPA receptors toward an artificial memory erasure

    TAKEMOTO Kiwamu, NAGAI Takeharu, TAKAHASHI Takuya

    20 ( 2 )   67 - 68   2011.8

     More details

    Language:English  

    CiNii Books

    researchmap

  • Serotonin as a mediator of cross-modal cortical reorganization. Reviewed

    Takahashi T

    Communicative & integrative biology   4   459 - 461   2011.7

     More details

  • 第13回 注目の遺伝子 Cross modal plasticityにおけるAMPA受容体の役割

    高橋琢哉

    分子精神医学   11 ( 2 )   126 - 128   2011.4

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 注目の遺伝子(第13回) Cross modal plasticityにおけるAMPA受容体の役割

    高橋 琢哉

    分子精神医学   11 ( 2 )   126 - 128   2011.4

     More details

    Language:Japanese   Publisher:(株)先端医学社  

    CiNii Books

    researchmap

  • Serotonin as a mediator of cross-modal cortical reorganization. Reviewed

    Takuya Takahashi

    Commun Integr Biol.   4 ( 4 )   459 - 461   2011.1

     More details

    Language:English   Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

    researchmap

  • 海馬依存的学習の分子細胞メカニズム

    高橋 琢哉

    第一三共生命科学研究振興財団研究報告集   27 ( 0 )   92 - 98   2011

     More details

    Language:Japanese   Publisher:第一三共生命科学研究振興財団  

    CiNii Books

    researchmap

  • Cholinergic activation is required for learning-dependent AMPA receptor delivery into the CA3-CA1 synapses

    Dai Mitsushima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   71   E376 - E376   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1651

    Web of Science

    researchmap

  • Sex difference of the effect of neonatal social isolation on experience driven synaptic delivery of AMPA receptors in rat barrel cortex

    Hirobumi Tada, Takuya Takahashi

    NEUROSCIENCE RESEARCH   71   E324 - E324   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1416

    Web of Science

    researchmap

  • The role of Semaphorin-PlexinA signaling in synaptic plasticity

    Aoi Takahashi, Naoya Yamashita, Susumu Jitsuki, Takuya Takahashi, Yoshio Goshima

    NEUROSCIENCE RESEARCH   71   E64 - E64   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.270

    Web of Science

    researchmap

  • The roles of Semaphorin-PlexinA signaling in synaptic plasticity

    Aoi Takahashi, Naoya Yamashita, Susumu Jitsuki, Takuya Takahashi, Yoshio Goshima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   115   131P - 131P   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  • P2-u20 Light induced inactivation technology for AMPA receptors

    Kiwamu Takemoto, Takeharu Nagai, Takuya Takahashi

    NEUROSCIENCE RESEARCH   71   E207 - E207   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.897

    Web of Science

    researchmap

  • Serotonin mediates cross-modal reorganization of cortical circuits

    Susumu Jitsuki, Takuya Takahashi

    NEUROSCIENCE RESEARCH   71   E57 - E57   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.242

    Web of Science

    researchmap

  • Mechanisms underlying disruption of cortical function by neonatal isolation

    Tomoyuki Miyazaki, Kenkichi Takase, Hirobumi Tada, Akane Sano, Daisuke Oya, Waki Nakajima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   71   E323 - E324   2011

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2011.07.1413

    Web of Science

    researchmap

  • シナプス機能の生後発達とその異常 in vivoでの経験依存的AMPA受容体シナプス移行(Postnatal development of synaptic function and its disorder Experience driven synaptic delivery of AMPA receptors in vivo)

    高橋 琢哉

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   1S13 - 5   2010.12

     More details

    Language:English   Publisher:(公社)日本生化学会  

    researchmap

  • 光操作によるAMPA受容体機能破壊技術の開発(Light induced loss of function technology for AMPA receptors in living cells)

    竹本 研, 永井 健治, 高橋 琢哉

    神経化学   49 ( 2-3 )   600 - 600   2010.8

     More details

    Language:English   Publisher:(一社)日本神経化学会  

    researchmap

  • 精神・神経活動の基盤としてのシナプス研究の最近の進歩 経験依存的AMPA受容体シナプス移行(Leading edge research of synapses as the basis for psychical activity Experience dependent synaptic delivery of AMPA receptors)

    高橋 琢哉

    神経化学   49 ( 2-3 )   458 - 458   2010.8

     More details

    Language:English   Publisher:(一社)日本神経化学会  

    researchmap

  • cross-modal plasticityにおける責任脳部位の解析(Brain regions responsible for the cross-modal reorganization of cortical circuit)

    川崎 泰輔, 藤本 章博, 實木 亨, 高橋 琢哉

    神経化学   49 ( 2-3 )   646 - 646   2010.8

     More details

    Language:English   Publisher:日本神経化学会  

    researchmap

  • セロトニンを介した皮質神経回路のcross-modalな再構成(Serotonin mediates cross-modal reorganization of cortical circuits)

    實木 亨, 高橋 琢哉

    神経化学   49 ( 2-3 )   696 - 696   2010.8

     More details

    Language:English   Publisher:(一社)日本神経化学会  

    researchmap

  • 海馬CA1におけるAMPA受容体のシナプス移行阻害 文脈学習と空間学習への異なる影響(Blocking of AMPA receptor delivery into hippocampal CA1 synapses: different effects on different tasks)

    美津島 大, 石原 康至, 佐野 亜加根, 高橋 琢哉

    神経化学   49 ( 2-3 )   739 - 739   2010.8

     More details

    Language:English   Publisher:(一社)日本神経化学会  

    researchmap

  • 乳仔期ストレスによる皮質機能障害のメカニズム(Mechanisms underlying disruption of cortical function by neonatal isolation)

    宮崎 智之, 高瀬 堅吉, マリナウ・ロバート, 高橋 琢哉

    神経化学   49 ( 2-3 )   500 - 500   2010.8

     More details

    Language:English   Publisher:(一社)日本神経化学会  

    researchmap

  • 脳科学のモデル実験動物 ストレスと動物モデル

    高橋琢哉

    生体の科学   61 ( 1 )   24 - 29   2010.2

     More details

  • Animal model of stress disorder

    高橋 琢哉

    生体の科学   61 ( 1 )   24 - 29   2010.1

     More details

    Language:Japanese   Publisher:金原一郎記念医学医療振興財団  

    researchmap

  • Effects of fentanyl citrate (fentanyl) and oxycodone hydrochloride hydrate (oxinorm) on formalin-induced pain behavior and the expression of phosphorylated cAMP response element-binding protein in the bed nucleus of the stria terminalis in female rats

    萩原 裕子, 舩橋 利也, 高橋 琢哉

    Yokohama medical journal   61 ( 1 )   19 - 24   2010.1

     More details

    Language:Japanese   Publisher:横浜市立大学医学会  

    researchmap

  • Serotonin mediates cross-modal reorganization of cortical circuits

    Susumu Jitsuki, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E344 - E344   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1522

    Web of Science

    researchmap

  • Light induced loss of function technology for AMPA receptors in living cells

    Kiwamu Takemoto, Takeharu Nagai, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E218 - E218   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.2537

    Web of Science

    researchmap

  • Hippocampus-dependent learning requires synaptic AMPA receptor delivery: effect of delivery blocking in behaving rats

    Dai Mitsushima, Kouji Ishihara, Yoshinori Kamiya, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   60   S84 - S84   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Mechanisms underlying disruption of cortical function by neonatal isolation

    Tomoyuki Miyazaki, Kenkichi Takase, Malinow Roberto, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E88 - E88   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.155

    Web of Science

    researchmap

  • Brain regions responsible for the cross-modal reorganization of cortical circuit

    Taisuke Kawasaki, Akihiro Fujimoto, Susumu Jitsuki, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E276 - E276   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1230

    Web of Science

    researchmap

  • Blocking of AMPA receptor delivery into hippocampal CA1 synapses: different effects on different tasks

    Dai Mitsushima, Kouji Ishihara, Akane Sano, Takuya Takahashi

    NEUROSCIENCE RESEARCH   68   E400 - E400   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2010.07.1776

    Web of Science

    researchmap

  • Experience-driven synaptic delivery of AMPA receptors

    Cell technology.   28 ( 9 )   920 - 924   2009.8

     More details

    Language:Japanese  

    researchmap

  • 精神医学と神経学の統合的展開 経験依存的AMPA受容体シナプス移行(Experience dependent synaptic delivery of AMPA receptors)

    高橋 琢哉

    神経化学   48 ( 2-3 )   175 - 175   2009.6

     More details

    Language:English   Publisher:(一社)日本神経化学会  

    researchmap

  • 視覚剥奪ラットのバレル皮質におけるセロトニンによるAMPA受容体のシナプスへの移行促進

    実木亨, 多田敬典, 高橋琢哉

    横浜医学   60 ( 1/2 )   164   2009.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • アミロイド前駆体蛋白(APP)のシナプス機能の解析

    高橋 琢哉

    ライフサイエンス振興財団年報   23   10 - 12   2009.3

     More details

    Language:Japanese   Publisher:(公財)ライフサイエンス振興財団  

    researchmap

  • SOCIAL ISOLATION PRODUCES GLUCOCORTICOID-MEDIATED DISRUPTION OF CORTICAL CIRCUIT FORMATION

    Tomoyuki Miyazaki, Kenkichi Takase, Hirobumi Tada, Dai Mitsushima, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   366 - 366   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • SEX DIFFERENCE OF THE EFFECT OF NEONATAL SOCIAL ISOLATION ON EXPERIENCE DRIVEN SYNAPTIC DELIVERY OF AMPA RECEPTORS IN RAT BARREL CORTEX

    Hirobumi Tada, Tomoyuki Miyazaki, Kasane Komiya, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   135 - 135   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Social isolation produces glucocorticoid-mediated disruption of cortical circuit formation

    Tomoyuki Miyazaki, Kenkichi Takase, Hirobumi Tada, Dai Mitsushima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S58 - S58   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.156

    Web of Science

    researchmap

  • BRAIN REGIONS RESPONSIBLE FOR THE CROSS-MODAL REORGANIZATION OF CORTICAL CIRCUIT

    Taisuke Kawasaki, Hiroki Matsuki, Susumu Jitsuki, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   188 - 188   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • ROLE OF Ca2+-PERMEABLE AMPA RECEPTORS IN THE GONADOTROPIN-RELEASING HORMONE (GnRH) SURGE GENERATOR

    Toshiya Funabashi, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   334 - 334   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Serotonin mediates cross modal reorganization of cortical circuit

    Susumu Jitsuki, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S67 - S67   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.216

    Web of Science

    researchmap

  • SEROTONIN FACILITATES AMPA RECEPTOR TRAFFICKING IN THE DEVELOPING BARREL CORTEX OF RATS WITH VISUAL DEPRIVATION

    Susumu Jitsuki, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   135 - 135   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Learning requires synaptic delivery of AMPA receptors at CA3-CA1 synapses

    Dai Mitsushima, Kouji Ishihara, Yoshinori Kamiya, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S68 - S68   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.219

    Web of Science

    researchmap

  • LOCALIZATION OF BRAIN REGION RESPONSIVE TO NEONATAL SOCIAL ISOLATION

    Hiroki Matsuki, Taisuke Kawasaki, Tomoyuki Miyazaki, Toshiya Funabashi, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   518 - 518   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Sex difference of the effect of neonatal social isolation on experience driven synaptic delivery of AMPA receptors in rat barrel cortex

    Hirobumi Tada, Tomoyuki Miyazaki, Kasane Komiya, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S42 - S42   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.051

    Web of Science

    researchmap

  • Dynamic changes in the AMPA receptor subunits compostion during the estrous cycle

    Toshiya Funabashi, Takuya Takahashi

    NEUROSCIENCE RESEARCH   65   S221 - S221   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.1235

    Web of Science

    researchmap

  • LEARNING REQUIRES SYNAPTIC DELIVERY OF AMPA RECEPTORS AT SCHAFFER COLLATERAL SYNAPSES IN THE DORSAL HIPPOCAMPUS

    Dai Mitsushima, Kouji Ishihara, Yoshinori Kamiya, Takuya Takahashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   176 - 176   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • 過食症におけるAMPA受容体シナプス移行の役割

    高橋 琢哉

    上原記念生命科学財団研究報告集   22   1 - 4   2008.12

     More details

    Language:Japanese   Publisher:(公財)上原記念生命科学財団  

    過食の機序を、空腹感を形成する視床下部外側野のシナプスにα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid(AMPA)受容体(GluR1-4)が移行することにより引き起こされるという仮説をたて、それを証明した。FUGWレンチウイルスを用いて、成熟したラットの中枢神経系の特定の部位に遺伝子を発現させる方法を確立した。4時間絶食後の一過性の過食に対する効果を検討した。雌性ラットの場合、雄性ラットと比較して、24時間絶食後、一過性に有意な摂食量の増加を認め、過食のモデルとして適当であることが示唆された。対照期間3日間の摂食量を100%として表記すると、GIuR1-et群の24時間絶食後の再摂食量は、GFP対照群と比較して、有意な差を認めなかった。側坐核、視床下部弓状核、および腹側被蓋野においても同様の結果であった。

    researchmap

  • 【神経回路の制御と脳機能発現のメカニズム 細胞移動・接着から記憶・学習・行動発現までの分子基盤解明と研究を躍進させる最新技術】分子レベルからみた回路形成 経験依存的AMPA受容体シナプス移行

    高橋 琢哉

    実験医学   26 ( 12 )   1880 - 1885   2008.7

     More details

    Language:Japanese   Publisher:(株)羊土社  

    われわれが新しいことを学んだり、経験するときに一体どのようなことが脳内に起こっているのであろうか?興奮性シナプスにおいて中心的役割を果たしているグルタミン酸作動性シナプスにおける可塑的変化は記録、学習をはじめとした経験依存的神経可塑性の基盤であると考えられている。グルタミン酸受容体の1つであるAMPA受容体の挙動はとりわけ注目を集めている。本稿では、記憶学習などの経験に伴って起こるAMPA受容体のシナプスへの移行について概説する。(著者抄録)

    researchmap

  • Kspot, a novel ubiquitin ligase, regulates synaptic activity

    Hirobumi Tada, Hirotaka James Okano, Hiroshi Takagi, Ikuko Yao, Toru Saiga, Masaki Matsumoto, Koiichi I. Nakayama, Haruo Kashima, Takuya Takahashi, Mitsutoshi Setou, Hideyuki Okano

    NEUROSCIENCE RESEARCH   61 ( 0 )   S218 - S218   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    We identified a novel ubiquitin ligase (E3), Kspot as a target molecule of a high titer autoantibody produced in the serum of a patient with stomach can cer, associated with psychiatric symptoms.Kspot is highly conserved througho ut species and expressed in the mammalian nervous system. In this study we d emonstrated that Kspot formed an SCF complex and mediated ubiquitination of cellular proteins. Furthermore, overexpression of Kspot in primary cultured rat hippocampal neurons resulted in a decrease in the miniature excitatory p ostsynaptic current frequency. We propose that Kspot plays an important role in the regulation of the neurotransmitter release at the presynaptic site. &lt;b&gt;[J Physiol Sci. 2008;58 Suppl:S123]&lt;/b&gt;

    Web of Science

    researchmap

  • Expression of the lentivirus carrying dominant negative of AMPA receptor subunit glutamate receptor 1 (GluR1), in the preoptic area (POA) delays the onset of puberty in female rats

    Funabashi Toshiya, Hagiwara Hiroko, Kimura Fukuko, Takahashi Takuya

    Proceedings of Annual Meeting of the Physiological Society of Japan   2008 ( 0 )   140 - 140   2008

     More details

    Publisher:PHYSIOLOGICAL SOCIETY OF JAPAN  

    The brain initiates activation of the gonadotropin-releasing hormone (GnRH) system at puberty onset. Since GnRH neurons are suggested to show a plasticity during postnatal development, remodeling of GnRH neurons may be involved in the onset of puberty. The present study was done by attempting to block plasticity in the GnRH neuronal network, by interfering with the synaptic delivery of GluR1 whose trafficking is critical in synaptic plasticity and thus necessary for memory. To this end, GluR1-C-tail, a dominant negative mutant of GluR1, was expressed in the POA of female rats at day 21 using lentivirus. GluR1-C-tail has been shown to act by competing with GluR1 for synaptic delivery during synaptic plasticity. As the result, the onset of puberty, by checking viginal opening, was significantly delayed. After that, the estrous cyclicity was checked by viginal smear and found that the rat injected with GluR1-C-tail exhibited a regular estrous cycle. However, the surge of luteinizing hormone (LH) secretion in the rat injected with GluR1-C-tail was significantly attenuated, compared to the control rat. Injection with GluR1-C-tail in mature rats had no effect on the surge of LH secretion. The present study suggests that GluR1-mediated plasticity occurs at the time of puberty and is important to maintain surge of LH secretion in adults. &lt;b&gt;[J Physiol Sci. 2008;58 Suppl:S140]&lt;/b&gt;

    researchmap

  • Serotonin facilitates AMPA receptor trafficking in the developing barrel cortex of rats with visual deprivation

    Susumu Jitsuki, Kenkichi Takase, Takuya Takahashi

    NEUROSCIENCE RESEARCH   61   S60 - S60   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Expression of AMPA receptor subunit glutamate receptor 1 [GluR1] in the preoptic area [POA] delays the onset of puberty in female rats

    Toshiya Funabashi, Hiroko Hagiwara, Fukuko Kimura, Takuya Takahashi

    NEUROSCIENCE RESEARCH   61   S108 - S108   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Social isolation disrupts experience-driven synaptic delivery of AMPA receptors in developing rat barrel cortex via glucocorticoid

    Tomoyuki Miyazaki, Kenkichi Takase, Dai Mitsushima, Takuya Takahashi

    NEUROSCIENCE RESEARCH   61   S60 - S60   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Role of CREB in the response of the bed nucleus of the stria terminalis (BST) to formalin-induced nociceptive stimuli in female rats

    Hagiwara Hiroko, Funabashi Toshiya, Arita Jun, Kumura Fukuko, Takahashi Takuya

    Proceedings of Annual Meeting of the Physiological Society of Japan   2008 ( 0 )   165 - 165   2008

     More details

    Publisher:PHYSIOLOGICAL SOCIETY OF JAPAN  

    Sex differences in the response to nociceptive stimuli have long been recognized in many species. For example, in rats, females are more sensitive to formalin-induced nociceptive stimuli than males, as revealed by behavioral test. However, the neural mechanism for sex differences in the response to nociceptive stimuli was still unclear. In the previous study, we showed that females were more sensitive to formalin-induced nociceptive stimuli than males, as revealed by behavioral test. We looked for a possible sex difference in the response of the brain to formalin-induced nociceptive stimuli by checking the expression of phosphorylated cAMP response element-binding protein (pCREB) as a marker of neural activity. We found that, in the bed nucleus of the stria terminalis lateral subdivision (BSTL), the number of cells expressing pCREB was increased 5-10 min after formalin injection in female rats but not in male rats. In the present study, we examined the function of CREB in the BSTL. We found that the expression of a dominant negative form of CREB (mCREB) using adenovirus vector, significantly attenuated the response to formalin only in females but not in males, suggesting that CREB in the BSTL play a role for controlling pain-related behavior only in females. &lt;b&gt;[J Physiol Sci. 2008;58 Suppl:S165]&lt;/b&gt;

    researchmap

  • Acetylcholine release during learning mediates synaptic delivery of AMPA receptors into Schaffer collateral synapses in the dorsal hippocampus

    Dai Mitsushima, Kouji Ishihara, Yoshinori Kamiya, Takuya Takahashi

    NEUROSCIENCE RESEARCH   61   S68 - S68   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • 中枢性食欲のコントロールのメカニズム 摂食行動の性差の神経基盤

    舩橋 利也, 貴邑 冨久子, 高橋 琢哉

    肥満研究   13 ( Suppl. )   134 - 134   2007.9

     More details

    Language:Japanese   Publisher:(一社)日本肥満学会  

    researchmap

  • CRMP1を標的とした統合失調症治療薬の創薬 (平成18年度研究奨励金受領報告) -- (精神神経作用に影響を与える物質の基礎と創薬)

    高橋琢哉

    東京生化学研究会助成研究報告集   22   72 - 75   2007

     More details

    Language:Japanese   Publisher:東京生化学研究会  

    CiNii Books

    researchmap

  • The role of LAR class protein tyrosine phosphatase in axon guidance

    F Nakamura, K Tachikawa, T Takahashi, SM Strittmatter, Y Goshima

    JOURNAL OF PHARMACOLOGICAL SCIENCES   94   14P - 14P   2004

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:JAPANESE PHARMACOLOGICAL SOC  

    Web of Science

    researchmap

  • In vivoにおける経験に依存したAMPA受容体のシナプスへの移行

    高橋 琢哉

    細胞工学   22 ( 12 )   1366 - 1371   2003.11

     More details

    Language:Japanese   Publisher:(株)学研メディカル秀潤社  

    LTPはシナプスに一定期間テタヌス刺激を加えることによりシナプス応答が長期間増強するようになるという現象で,この分子メカニズムは明らかになりつつある.in vitroで培養した海馬スライスを用いた実験により,AMPAタイプグルタミン酸受容体のGluR1がLTP誘導刺激によりシナプスに移行することが明らかになった.最近,著者等はこのGluR1のシナプス移行がin vivoにおいても経験依存的に起こっているということを見つけた.そこで,LTPと記憶の関係について最新の知見を交えて概説した

    researchmap

  • Special Review セマフォリンの情報伝達

    高橋琢哉

    細胞工学   19 ( 8 )   1205 - 1213   2000.8

     More details

    Language:Japanese   Publisher:秀潤社  

    CiNii Books

    researchmap

  • セマフォリンの情報伝達

    高橋琢哉

    細胞工学   19 ( 8 )   1205 - 1213   2000.7

     More details

  • 神経軸索反発因子セマフォリンの情報伝達におけるニューロピリン/プレキシン複合体の役割

    高橋琢哉

    実験医学   18 ( 3 )   366 - 370   2000.2

     More details

    Language:Japanese  

    researchmap

  • 2つのセマフォリン受容体 ニューロピリンとプレキシン

    高橋 琢哉

    細胞工学   18 ( 5 )   690 - 692   1999.5

     More details

    Language:Japanese   Publisher:(株)学研メディカル秀潤社  

    CiNii Books

    CiNii Research

    researchmap

  • セマフォリンファミリーのシグナル伝達 ニューロピリンの役割

    高橋 琢哉

    細胞工学   17 ( 4 )   571 - 573   1998.4

     More details

    Language:Japanese   Publisher:(株)学研メディカル秀潤社  

    CiNii Books

    researchmap

  • Semaphorins:a family of repulsive factors of neuronal growth cone.

    中村史雄, 高橋琢哉, Strittmatter, S

    細胞工学   16   1116 - 1123   1998

     More details

    Language:Japanese  

    researchmap

  • 脳の高次機能の鍵を握る神経発生のしくみ セマフォリン 神経成長円錐の反発因子

    中村 史雄, 高橋 琢哉

    細胞工学   16 ( 8 )   1116 - 1123   1997.8

     More details

    Language:Japanese   Publisher:(株)学研メディカル秀潤社  

    CiNii Books

    researchmap

  • 神経形成 側方抑制によるパターン形成 Notchシグナリングによる側方抑制

    高橋 琢哉, 岡野 栄之

    実験医学   14 ( 8 )   1107 - 1117   1996.6

     More details

    Language:Japanese   Publisher:(株)羊土社  

    researchmap

  • Lateral Inhibition by Notch-signaling

    高橋琢哉, 岡野栄之

    実験医学   14   1107 - 1117   1996

     More details

  • 脳研究と実験動物 ショウジョウバエ 神経系の分化

    高橋 琢哉, 岡野 栄之

    Brain Medical   6 ( 2 )   119 - 126   1994.6

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    researchmap

▼display all

Presentations

  • Experience driven synaptic delivery of AMPA receptors in vivo. Invited

    高橋琢哉

    第33回日本分子生物学会年会(BMB2010)  2010.12 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    第39回日本認知症学会学術集会 Web開催  2020.11 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • AMPA受容体のtranslational medicine Invited

    高橋 琢哉

    桜山てんかん研究会 Web開催  2020.10 

     More details

  • 精神神経疾患におけるAMPA受容体シナプス移行

    高橋琢哉

    第3回公開シンポジウム  2012.2 

     More details

  • AMPA受容体を切り口とした精神神経疾患の病態解明~てんかんの話題も含めて~ Invited

    高橋 琢哉

    精神科領域講演会~AMPAの可能性を探る~ Web開催  2021.1 

     More details

  • 精神神経疾患におけるAMPA受容体シナプス移行

    高橋琢哉

    「先端医科学研究センターの研究開発プロジェクト」第8回研究報告会  2012.2 

     More details

  • Synaptic Plasticity From bench to bedside Invited

    2020.12 

     More details

  • 社会的に隔離された環境が脳に与える影響の分子細胞メカニズム Invited

    高橋琢哉

    脳科学研究戦略推進プログラム 公開シンポジウム  2012.9 

     More details

  • AMPA受容体を切り口とした精神神経疾患の病態解明~てんかんの話題も含めて~ Invited

    高橋 琢哉

    Psychiatry WEB seminar in 目黒  2021.2 

     More details

  • 精神疾患診断治療ターゲットとしてのAMPA受容体シナプス移行異常 Invited

    高橋琢哉

    第3回泌尿器科フロンティアセミナー  2012.8 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    精神科医のためのてんかん診療Webセミナー~その精神症状の正体は?~  2021.1 

     More details

  • Environment regulates experience-driven synaptic delivery of AMPA receptors Invited

    高橋琢哉

    第90回日本生理学大会  2013.3 

     More details

  • AMPA受容体のtranslational medicine Invited

    高橋 琢哉

    AMPA受容体を語る会 Web開催  2021.3 

     More details

  • 養育環境が脳に影響を及ぼすメカニズム Invited

    高橋琢哉

    横浜市立大学先端医科学研究センター市民講座  2012.12 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体のtranslational medicine Invited

    高橋 琢哉

    第23回日本ヒト脳機能マッピング学会 共催セミナー Web開催  2021.3 

     More details

  • AMPA受容体可視化のためのPETプローブ Invited

    高橋琢哉

    橋渡し研究加速ネットワークシンポジウム  2017.1 

     More details

  • AMPA受容体標識PET Probeの開発~ペランパネルの可能性~ Invited

    高橋琢哉

    第46回日本臨床神経生理学会学術大会(ランチョンセミナー)  2016.10 

     More details

    Language:Japanese  

    researchmap

  • シナプス生理学のトランスレーショナルアプローチ Invited

    高橋琢哉

    第13回ニューロリハビリテーション学会  2022.2 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 学習の分子細胞メカニズム

    高橋琢哉

    第92回日本生理学大会  2015.3 

     More details

  • シナプス生理学のtranslational medicine Invited

    高橋琢哉

    第10回 東北パーキンソン病研究会  2021.9 

     More details

  • 経験依存的AMPA受容体シナプス移行

    高橋琢哉

    慶應神経発生研究会2014  2014.12 

     More details

  • シナプス生理学のトランスレーショナルアプローチ Invited

    高橋琢哉

    第8回神経疾患画像研究会  2021.9 

     More details

  • 恐怖記憶が形成される際の脳神経細胞の分子メカニズム Invited

    高橋琢哉

    第8回セファロ・ニューロ・サイコリウマトロジー研究会  2015.10 

     More details

  • 新規AMPA受容体標識PET probeによるてんかん病態の解明

    高橋琢哉

    第54回日本てんかん学会学術集会  2021.9 

     More details

  • シナプス可塑性:基礎研究から臨床応用へ Invited

    高橋琢哉

    第57回日本小児神経学会学術集会  2015.5 

     More details

  • シナプス生理学のトランスレーショナルアプローチ Invited

    高橋琢哉

    第117回日本精神神経学会学術総会  2021.9 

     More details

  • トレーニング依存的に作用する脳卒中後のリハビリテーション効果促進薬の開発

    高橋琢哉

    第41回日本脳卒中学会総会  2016.4 

     More details

  • Translational medicine of glutamate AMPA receptor

    Takuya Takahashi

    IRCN(International Research Center for Neurointelligence)セミナー  2021.11 

     More details

  • AMPA受容体を切り口とした精神神経疾患の新規診断治療法 Invited

    高橋琢哉

    第3回生物学的自閉症研究会  2016.2 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 新規AMAP受容体標識PET probeによるてんかん病態の解明 Invited

    高橋琢哉

    福島県てんかん懇話会 学術講演会  2021.10 

     More details

  • AMPA受容体標識PET Probeの開発 Invited

    高橋琢哉

    第39回日本神経科学大会(ランチョンセミナー)  2016.7 

     More details

  • AMPA受容体のtranslational medicine

    高橋琢哉

    【次世代脳】冬のシンポジウム「次世代マルチスケール脳企画」脳基礎神経科学と臨床精神が融合したブレークスルー研究の育て方  2021.12 

     More details

  • Synaptic plasticity:from bench to bedside

    Takuya Takahashi

    Current Trends and Future Directions of Synaptic Plasticity Research.  2016.6 

     More details

  • シナプス生理学のtranslational medicine Invited

    高橋琢哉

    第49回日本頭痛学会総会  2021.11 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • グルタミン酸AMPA受容体のtranslational medicine

    高橋琢哉

    第44回日本神経科学大会  2021.7 

     More details

    Presentation type:Symposium, workshop panel (public)  

    researchmap

  • AMPA受容体標識PET probeの開発 Invited International conference

    高橋琢哉

    第58回日本神経学会学術大会 第23回世界神経学会議同時開催.  2017.9 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Synaptic Plasticity from bench to bedside

    高橋琢哉

    University of Illinois at Chicago  2017.3 

     More details

    Language:English   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • A Novel PET Tracer for AMPA Receptors Characterizes Neuropsychiatric Disorders in Human.

    Takuya Takahashi

    33rd CINP Hybrid World Congress of Neuropsychopharmacology  2022.6 

     More details

  • Synaptic Plasticity from bench to bedside. Invited

    高橋琢哉

    University of Illinois Urbana-Champaign Campus  2017.3 

     More details

    Language:English   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Synaptic Plasticity as a Target for Stroke Recovery: From Lab Bench to Human Bedside

    Takuya Takahashi

    2022 McDowell Symposium  2022.5 

     More details

  • Synaptic plasticity: from bench to bedside. Invited

    高橋琢哉

    横浜市大リハビリテーション科弘嗣会総会  2017.4 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • ヒト生体におけるシナプス可塑性の可視化と操作

    高橋 琢哉

    NEURO2022  2022.7 

     More details

    Presentation type:Symposium, workshop panel (public)  

    researchmap

  • シナプスの可塑性:基礎から臨床へ Invited

    高橋琢哉

    第94回日本生理学会大会  2017.3 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプス生理学のトランスレーショナルメディシン Invited

    高橋琢哉

    第59回日本リハビリテーション医学会学術集会スポンサード講演  2022.6 

     More details

  • 基礎的知見から考えるAMPA受容体の役割 Invited

    高橋琢哉

    神奈川県フィコンパ発売1周年記念講演会  2017.7 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Translational medicine with PET probe for AMPA receptors. Invited

    Takuya Takahashi

    13th Congress of the World Federation of Nuclear Medicine and Biology. Lincheon Seminar2  2022.9 

     More details

  • AMPA受容体PET probeの開発~てんかん診療の新たな展開~ Invited

    高橋琢哉

    第59回日本小児神経学会学術集会  2017.6 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 「柔軟な脳」のしくみを探る ~神経と神経のつなぎ目:シナプスの不思議~

    高橋琢哉

    第9回脳科学研究戦略推進プログラム サイエンスカフェ  2014.3 

     More details

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    第62回日本小児神経学会 (ランチョンセミナー) Web開催  2020.8 

     More details

  • 神経疾患における翻訳後修飾と創薬

    高橋琢哉

    文科省イノベーション整備事業. 第5回公開シンポジウム  2014.8 

     More details

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋 琢哉

    AMPA受容体とペランパネルAdvanced Seminar  2019.10 

     More details

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋 琢哉

    静岡神経内科懇話会  2019.9 

     More details

  • Synaptic Plasticity: from bench to bedside Invited

    高橋 琢哉

    第6回アジア神経精神薬理学会/第49回日本神経精神薬理学会/第29回日本臨床精神神経薬理学会 共催シンポジウム  2019.10 

     More details

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    これからのてんかん診療を考える会  2019.7 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性の原理に基づいた精神神経疾患の生理学的根本原理 Invited

    高橋琢哉

    第10回日本脳血管・認知症学会  2019.8 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 地道な基礎神経科学から創薬へのブレークスルー Invited International conference

    高橋琢哉

    Neuro2019  2019.7 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    Psychiatry disorder & Epilepsy Seminar in Sapporo  2019.8 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    AMPA受容体を考える会in市川  2019.8 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    第12回 NCU Life Science Seminar  2020.1 

     More details

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    第39回日本認知症学会学術集会 Web開催  2020 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • Experience driven synaptic delivery of AMPA receptors in vivo Invited

    高橋琢哉

    慶応大学医学部 COEセミナー 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 基礎と臨床の融合研究から見るAMPA受容体の可能性

    高橋 琢哉

    精神科AMPA受容体を考える会  2020.1 

     More details

  • 基礎と臨床の融合研究から見るAMPA受容体の可能性 Invited

    高橋 琢哉

    AMPA受容体を考える会  2020.1 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo Invited

    高橋琢哉

    理化学研究所  2006 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 新規AMPA受容体標識PETprobeによるてんかん病態の解明 Invited

    高橋 琢哉

    第53回日本てんかん学会学術集会(ランチョンセミナー)  2019.11 

     More details

  • 創薬と神経画像研究 Invited

    高橋 琢哉

    第49回日本神経精神薬理学会  2019.10 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 新規AMPA受容体標識PETprobeによるヒト精神神経疾患の病態解明 Invited

    高橋 琢哉

    第38回日本認知症学会学術集会(イブニンセミナー)  2019.11 

     More details

  • 新規AMPA受容体標識PETprobeによる精神・神経疾患病態の解明 Invited

    高橋 琢哉

    第59回日本核医学会学術集会(ランチョンセミナー)  2019.11 

     More details

  • Visualization of AMPA Receptors in Patients With Depression, Bipolar Disorder, and Schizophrenia: The First PET Imaging Study.

    高橋 琢哉

    ACNP(American College of Neuropsychopharmacology)2019 58th Annual Meeting, Orand  2019.12 

     More details

  • AMPA-PET Invited

    高橋 琢哉

    Fycompa Medical Symposia in Incheon  2019.11 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 経験依存的AMPA受容体シナプス移行.

    高橋琢哉

    第32回日本神経科学大会,  2009.9 

     More details

    Language:English   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • シナプス生理学のtranslational medicine Invited

    Progress in Mind Japan RC Webinar 第3回  2022.7 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Facilitation of Synaptic AMPA Receptor Delivery Leading to the Acceleration of Recovery of Motor Function with Rehabilitation after Brain lnjury Invited International conference

    高橋琢哉

    第58回日本神経学会学術大会 第23回世界神経学会議同時開催  2017.9 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • AMPA受容体を切り口とした精神神経疾患の病態解明 Invited

    高橋 琢哉

    地域医療Webセミナー~てんかんとAMPA受容体を考える~  2022.9 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Synaptic plasticity: from bench to bedside. Invited

    高橋琢哉

    第40回日本神経科学大会  2017.7 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • Translational medicine with PET tracer for glutamate AMPA receptor Invited

    Takuya Takahashi

    13th Congress of the World Federation of Nuclear Medicine and Biology.  2022.9 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • AMPA受容体標識PETプローブを用いた精神神経疾患横断的研究 Invited

    高橋琢哉

    脳とこころの研究 第二回公開シンポジウム “脳を考える”  2017.3 

     More details

  • シナプス生理学のトランスレーショナルアプローチ Invited

    高橋琢哉

    第30回大分精神科学術懇話会  2022.4 

     More details

  • 新規AMPA受容体標識PET probe によるてんかん病態の解明 Invited

    高橋琢哉

    第4回Glutamate Conference 2022  2022.3 

     More details

  • 新規AMPA受容体PETイメージング製剤によるてんかん患者脳イメージング Invited

    高橋琢哉

    第51回日本てんかん学会学術集会  2017.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • AMPA受容体のtranslational medicine Invited

    高橋 琢哉

    第12回日本神経病理学会 東海・北陸地方会  2023.1 

     More details

  • AMPA受容体と精神疾患 Invited

    高橋琢哉

    医療心理懇話会 第2回集会  2017.10 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • Translational medicine of synapse physiology Invited

    高橋 琢哉

    山梨大学第32回GLIACセミナー  2022.11 

     More details

  • AMPA受容体PET probeの開発~ペランパネルの抗てんかん作用の科学的根拠~ Invited

    高橋琢哉

    AMPAエキスパートセミナー  2017.11 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体のtranslational medicine

    高橋 琢哉

    関西医科大学 精神神経科セミナー  2023.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原生中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第51回日本てんかん学会学術集会  2017.11 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体標識PETトレーサー([11C]K-2)によるシナプス生理学のtranslational medicine Invited

    高橋 琢哉

    第15回関東脳核医学研究会  2023.3 

     More details

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    てんかん診療セミナー~ペランパネルの未来~  2017.11 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Visualization of AMPA receptor in human brain. Invited

    Takuya Takahashi

    The 4th International Taiwanese congress of Neurology & Annual Meeting of Taiwan Neurological Society (4th ITCN 2023 AMTNS)  2023.4 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • AMPA受容体 ~基礎研究の根拠に基づく臨床応用~ Invited

    高橋琢哉

    第2回城南地区てんかん診療を考える会  2017.11 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体のtranslational medicine Invited

    高橋 琢哉

    Neurology Seminar ~てんかんとAMPA受容体を考える~  2023.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    TOYAMA Epilepsy Sminar(第一報)~AMPA受容体の新しい話題~  2017.11 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体PET probeの開発 ~ペランパネルの抗てんかん作用の科学的根拠~ Invited

    高橋琢哉

    Perampanel Expert Forum①  2017.11 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • First PET Imaging of AMPA Receptors in Schizophrenia, Bipolar Disorder, Depression, and Autistic Spectrum Disorders. Invited

    Takuya Takahashi

    34th CINP World Congress of Neuropsychopharmacology  2023.5 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • てんかんとAMPA受容体の関連はここまで見えた~AMPA受容体標識PET probe研究からの最新知見~ Invited

    高橋 琢哉

    第55回日本てんかん学会学術集会 ランチョンセミナー  2022.9 

     More details

  • 新規AMPA受容体 PETイメージング製剤の開発. Invited

    高橋琢哉

    第57回日本核医学会学術総会  2017.10 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス生理学のtranslational medicine Invited

    高橋 琢哉

    第102回慶應医学会総会・シンポジウム  2022.11 

     More details

  • Novel PET probe to visualize AMPA receptors in living human brain. Invited

    高橋琢哉

    第57回日本核医学会学術総会  2017.10 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプス生理学のtranslational medicine Invited

    高橋 琢哉

    第49回日本小児臨床薬理学会学術集会 ランチョンセミナー  2022.11 

     More details

  • トラウマ記憶を光操作により消去する新規技術の開発 Invited

    高橋琢哉

    第8回イノベーションシステム整備事業 先端融合領域イノベーション創出拠点形成プログラム 翻訳後修飾プロテオミクス医療研究拠点の形成プロジェクト国際公開シンポジウム  2018.1 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • AMPA受容体PET probeの開発 ~ペランパネルの抗てんかん作用の科学的根拠~ Invited

    高橋琢哉

    フィコンパ発売1周年記念講演会  2017.12 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Novel PET probe to visualize AMPA receptors in living human brain. Invited

    高橋琢哉

    The 17th mind Brain Cinference 2018 “Reimagine Mind Brain Sciences through Photons:Uniting Biomedical and Enginneering Innvations  2018.2 

     More details

    Language:English   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Synaptic plasticity: from bench to bed side Invited

    高橋琢哉

    Campbell Family Research Institute Speecial Seminar.  2018.2 

     More details

    Language:English   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Development of PET tracer for AMPA receptors. Invited

    高橋琢哉

    The UK-Japan Spring Neuroscience Symposium. London  2018.3 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • AMPA受容体PET Probeの開発~ペランパネルの抗てんかん作用の科学的根拠~ Invited

    高橋琢哉

    城南てんかんセミナー  2018.2 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    脳機能画像カンファレンス  2018.3 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    最新のてんかん診療セミナーin 呉西  2017.12 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体PETイメージング製剤によるてんかん焦点同定の補助診断薬としての臨床研究 Invited

    高橋琢哉

    第3回橋渡し研究 戦略的推進プログラムシンポジウム  2017.12 

     More details

    Presentation type:Poster presentation  

    researchmap

  • AMPA受容体PET probeの開発 ~ペランパネルの抗てんかん作用の科学的根拠~ Invited

    高橋琢哉

    Perampanel Expert Forum  2017.12 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 分子細胞生物学に基づいたリハビリテーション医学 Invited

    高橋琢哉

    第55回日本リハビリテーション医学会学術集会Merz社共催セミナー(スイーツセミナー1)  2018.6 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第56回北陸神経内科懇話会  2018.6 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体:基礎研究の根拠に基づいた臨床 Invited

    高橋琢哉

    第30回九州臨床神経生理研究会 in OKINAWA  2018.7 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    エーザイ社内講演会  2018.7 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Synaptic plasticity: from bench to bedside

    高橋琢哉

    昭和薬科大学(特別講義)  2018.9 

     More details

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    てんかん診療セミナーin豊橋  2018.9 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • A novel PET tracer for AMPA receptors to visualize epileptic focus Invited

    高橋琢哉

    第59回日本神経学会学術大会  2018.5 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    Keio Child Neurology Network  2018.3 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体標識PET Probeの開発 Invited

    高橋琢哉

    第44回沖縄県IVR研究会  2018.6 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    エーザイ社内講演会  2018.6 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Translational medicine of glutamate AMPA receptors

    高橋 琢哉

    第46回日本神経科学大会  2023.8 

     More details

    Presentation type:Symposium, workshop panel (public)  

    researchmap

  • Translational medicine of synapse physiology Invited

    高橋 琢哉

    第64回日本神経病理学会総会学術研究会/第66回日本神経化学大会 合同大会  2023.7 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • てんかん症例の脳機能の調整におけるシナプス可塑性のシン解釈~AMPA受容体標識PET probe研究からの最新知見~ Invited

    高橋 琢哉

    グルタメートカンファランス in 県南~AMPA受容体を語る会~  2023.9 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • AMPA受容体のtranslational medicine ~AMPA受容体医学の創生を目指して~ Invited

    高橋 琢哉

    精神科医のためのてんかん診療Webセミナー  2023.8 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス生理学のTranslational Medicine Invited

    高橋 琢哉

    第10京都小児てんかん懇話会  2024.1 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん症例の脳機能の調整におけるシナプス可塑性のシン解釈~AMPA受容体標識PET probe研究からの最新知見~ Invited

    高橋 琢哉

    第56回日本てんかん学会学術集会 ランチョンセミナー2(共催セミナー)  2023.10 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス生理学のtranslational medicine Invited

    高橋 琢哉

    脳神経内科医のためのNeuro Conference in 城南  2024.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん症例の脳機能調整におけるシナプス可塑性のシン解釈~AMPA受容体標識PET probe研究の最前線~ Invited

    高橋 琢哉

    第26回日本ヒト脳機能マッピング学会 スポンサードシンポジウム~AMPA可視化による脳機能の探索~  2024.2 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • AMPA受容体のtranslational medicine ~てんかんの病態解明を目指して~ Invited

    高橋琢哉

    第32回 東京臨床脳画像解析研究会  2021.6 

     More details

  • Molecular mechanisms underlying experience dependent synaptic plasticity

    Takuya Takahashi

    Current Trends and Future Directions of Synaptic Plasticity Reseach  2013.7 

     More details

  • AMPA receptor PET study in epilepsy surgery candidates. Invited

    Takuya Takahashi

    13th Asian & Oceanian Epilepsy Congress (13th AOEC)  2021.6 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプス可塑性:基礎から臨床へ Synaptic Plasticity: from bench to bedside

    高橋琢哉

    日米科学技術協力事業「脳研究」分野における情報交換セミナー  2019.9 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 経験依存的AMPA受容体シナプス移行.

    高橋琢哉

    第52回日本神経化学会大会,  2009.6 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    第43回日本神経科学会 (ランチョンセミナー) Web開催  2020.7 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo. Invited

    高橋琢哉

    東大医学系研究科疾患生命工学センターセミナー、  2010.7 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 発育期社会的隔離ストレスに関連した機能分子スクリーニング系の開発. Invited

    高橋琢哉

    「脳科学研究戦略推進プログラム」平成22年度分科会  2010.7 

     More details

    Language:English   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • AMPA受容体を切り口とした精神神経疾患の病態解明 Invited

    高橋 琢哉

    精神科てんかん診療Webセミナー  2020.10 

     More details

  • 基礎と臨床の融合研究から見るAMPA受容体の可能性 Invited

    高橋 琢哉

    Glutamate Conference  2020.2 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo. Invited International conference

    高橋琢哉

    Albert Einstein College of Medicine  2006 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 基礎と臨床の融合研究から見るAMPA受容体の可能性, Invited

    高橋 琢哉

    精神科カンファレンスセミナー  2020.2 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo Invited

    高橋琢哉

    三菱化学生命科学研究所  2006 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性:基礎から臨床へ

    高橋 琢哉

    先端医科学研究センター市民講座  2020.2 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo. Invited International conference

    高橋琢哉

    National Institute of Health  2006 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    高橋 琢哉

    第93回日本薬理学会年会 紙上開催  2020.3 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • Experience driven synaptic delivery of AMPA receptors in vivo. Invited International conference

    高橋琢哉

    Yale University  2006 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Synaptic Plasticity: From Bench to Bedside. Invited

    高橋 琢哉

    Medical Workshop, Eisai Inc. in New Jersey  2020.2 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo Invited

    高橋琢哉

    日本生理学会大会  2007 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    精神科医のためのてんかん診療Webセミナー~その精神症状の正体は?~  2020.7 

     More details

  • Experience driven synaptic delivery of AMPA receptors in vivo. Invited

    高橋琢哉

    東京医科歯科大学  2007 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Development and Application of Novel PET Tracer for AMPA Receptors Invited

    Takuya Takahashi

    SNMMI2020 Annual Meeting VIRTUAL Edition Satellite Lunch Symposium, Web seminar  2020.7 

     More details

  • シナプス生理学のtranslational medicine Invited

    高橋 琢哉

    第8回CEPD研究会・年会  2023.5 

     More details

    Presentation type:Oral presentation (keynote)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第52回日本てんかん学会学術集会(ランチョンセミナー)  2018.10 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    広島神経疾患研究会  2018.10 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプスの可塑性:基礎から臨床 Invited

    高橋琢哉

    NPO法人中途障害者地域活動センター ライブアップ金沢  2018.11 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    千葉精神神経科診療所協会理事会講演会  2018.11 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性:基礎から臨床へ Invited

    高橋琢哉

    第28回日本臨床精神神経薬理学会第48回日本神経精神薬理学会合同年会  2018.11 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • シナプスの可塑性:基礎から臨床 Invited

    高橋琢哉

    NPO法人中途障害者地域活動センター ライブアップ金沢  2018.11 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • Novel Pet Probe to Visualize AMPA Receptors in Living Human Brain

    Takuya Takahashi

    ACNP(American College of Neuropsychopharmacology) 57th Annual Meeting  2018.12 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 新規AMPA受容体標識PETトレーサーの開発 Invited

    高橋琢哉

    第19回日本脳神経核医学研究会  2018.11 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第77回日本脳神経外科学会(アフタヌーンセミナー)  2018.10 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性のトランスレーショナルアプローチ Invited

    高橋琢哉

    第77回日本脳神経外科学会  2018.10 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~, Invited

    高橋琢哉

    高橋琢哉, AMPA受容体拮抗薬ペランパネルについて考える会  2019.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第11回名古屋分子標的イメージングセミナー  2019.2 

     More details

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第60回京滋北奈良てんかん懇話会  2019.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 新規AMPA受容体標識PET probe によるてんかん病態の解明 Invited

    高橋琢哉

    久留米Glutamate Conference  2019.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • CRMP2 Binding Compound, Edonerpic Maleate, Accelerates Motor Function Recover from Brain Damage

    高橋琢哉

    9th Federation of the Asian and Oceanian Physiological Societies Congress  2019.3 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • てんかん治療におけるNaチャネルの重要性 Invited

    高橋琢哉

    Epilepsy Web Seminar in Yokohama  2019.3 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 新規AMPA受容体標識PET probeによるてんかん病態の解明 Invited

    高橋琢哉

    今治市医師会医学講演会  2019.4 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性のトランスレーショナルアプローチ Invited

    高橋琢哉

    日本学術会議シンポジウム 生体イメージングから創薬へ  2019.1 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第20回神奈川県脳神経外科集談会  2019.2 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • Novel PET probe to visualize AMPA receptors in living human brain

    高橋琢哉

    革新脳国際シンポジウム  2019.1 

     More details

  • シナプス可塑性:基礎研究から臨床実装へ Invited

    高橋琢哉

    第56回日本リハビリテーション医学会  2019.6 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 分子細胞生物学に基づいたリハビリテーション医学 Invited

    高橋琢哉

    第56回日本リハビリテーション医学会  2019.6 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 新規AMPA受容体標識PET probeによるてんかん病態の解明 Invited

    高橋琢哉

    第74回岡山てんかん懇話会  2019.7 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    第3回BTSG研究会  2019.7 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    Perampanel Epilepsy Seminar  2019.7 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 精神・神経疾患におけるAMPA型グルタミン酸受容体の可視化 Invited

    高橋琢哉

    Neuro-Imaging Experts Advisory Board Meeting  2019.7 

     More details

  • Synaptic Plasticity: from bench to bedside Invited

    Takuya Takahashi

    2019.5 

     More details

  • シナプス可塑性:基礎から臨床へ Invited

    高橋琢哉

    第56回日本臨床分子医学会学術集会  2019.4 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~

    高橋琢哉

    フィコンパてんかんセミナー  2019.6 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • てんかん原性中核分子としてのAMPA受容体~新規AMPA受容体可視化技術により見えてきたこと~ Invited

    高橋琢哉

    AMPA受容体を考える会  2019.5 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • シナプス可塑性の基礎研究を基盤とした診断治療薬の開発 Invited

    高橋琢哉

    フォーラム富山「創薬」第50回研究会  2019.9 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

▼display all

Industrial property rights

▼display all

Awards

  • 令和3年度 科学技術分野 文部科学大臣表彰 科学技術賞(研究部門)

    2021.4   文部科学省   シナプス可塑性のトランスレーショナル研究

    高橋 琢哉

     More details

  • 第34回2019年度 塚原仲晃記念賞

    2020.3   公益財団法人ブレインサイエンス振興財団   神経回路形成のメカニズム解明と臨床応用

     More details

  • 学長賞

    2019.3   横浜市立大学  

    高橋琢哉

     More details

  • 北里賞

    2013.5   慶應義塾大学医学部・医学研究科   機能的ニューロンネットワーク形成の分子メカニズムの研究

    高橋琢哉

     More details

  • 理事長賞

    2013.3   横浜市立大学  

    高橋琢哉

     More details

  • Young Investigator Award

    2005   NARSAD: The National Alliance For Research  

    高橋琢哉

     More details

  • Young Investigator Award

    2002   Cure Autism Now Foundation  

    高橋琢哉

     More details

  • The John Spangler Nicholas Prize (最優秀学位論文賞)

    2000   Yale大学  

    高橋琢哉

     More details

▼display all

Research Projects

  • 脳内AMPA受容体密度の変化に着目したアンジェルマン症候群の病態解明

    2021.4 - 2024.3

    日本医療研究開発機構  難治性疾患実用化研究事業 

      More details

    Authorship:Principal investigator 

    researchmap

  • 脳卒中患者の機能回復における臨界期の回路研究

    Grant number:20H05922  2020.11 - 2025.3

    日本学術振興会  科学研究費助成事業 学術変革領域研究(A)  学術変革領域研究(A)

    高橋 琢哉, 阿部 弘基

      More details

    Grant amount:\123370000 ( Direct Cost: \94900000 、 Indirect Cost:\28470000 )

    本研究課題で実施する研究はa)亜急性期脳卒中患者のAMPA PET、GABA PETのダブルイメージング , b)慢性期脳卒中患者のBMI介入前後のAMPA PET、GABA PETのダブルイメージング とした。これらの研究を特定臨床研究として実施するために、CROとの契約を行った。CROはエスアールディ、ヌーベルプラスの2社とした。また協働研究機関(慶應義塾大学、横浜市立脳卒中・神経脊椎センター)と定期的なミーティングを行った。上記、研究a)、研究b)については臨床研究計画の素案の作成も行った。さらに、GABA PET検査の準備として、[11C]flumazenilの合成準備を行った。

    researchmap

  • Inducing lifelong plasticity (iPlasticity) by brain rejuvenation: elucidation and manipulation of critical period mechanisms

    Grant number:20H05914  2020.11 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Transformative Research Areas (A)  Grant-in-Aid for Transformative Research Areas (A)

      More details

    Grant amount:\235430000 ( Direct Cost: \181100000 、 Indirect Cost:\54330000 )

    researchmap

  • リハビリテーション効果促進薬・エドネルピクの生物学的基盤と適応拡大

    Grant number:20H00549  2020.4 - 2023.3

    日本学術振興会  科学研究費助成事業 基盤研究(A)  基盤研究(A)

    高橋 琢哉, 實木 亨, 阿部 弘基

      More details

    Grant amount:\45630000 ( Direct Cost: \35100000 、 Indirect Cost:\10530000 )

    2020年度はエドネルピク (T-817MA)のサル脊髄損傷モデルでのリハビリテーション促進効果の検討を開始した。この研究は東京都医学総合研究所の霊長類実験施設で行った。まず、行動実験課題のための装置を構築し、実験記録のための撮影条件を整えた。行動実験課題はreaching taskとgrasping taskの2種類とした。次に、サルを用いて行動実験課題を実際に行って、運動学習の成立を確認した。運動学習の成立が確認された後に、脊髄損傷(C6/7の半切)を行った。この損傷を行うと手指巧緻運動が障害されるが、上肢近位や下肢の麻痺は生じないか軽度であった。2020年度は、合計3頭のサルに脊髄損傷を行った、エドネルピクまたは溶媒を筋肉注射で投与し経時的に運動機能の回復経過を評価した。この評価は記載時点も継続している。また、薬効の電気生理学的評価として皮質内微小電気刺激法(ICMS)も立ち上げた。脊髄損傷後に溶媒を投与して運動機能の回復経過を評価したサルにICMSを行った(記載時点も継続中)。エドネルピクの作用機序の解明のために、chemical LTP誘導下でのエドネルピクのactin/cofilin活性可能をFRAP法(fluoroscenece recovery after photobleaching法)で調べた(現在解析中)。

    researchmap

  • AMPA受容体の解析を用いたタウオパチー病態における神経回路変化の動的観察

    2019.4 - 2024.3

    日本医療研究開発機構 革新的技術による脳機能ネットワークの全容解明プロジェクト 

    高橋琢哉

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • The synaptic insufficient delivery hypothesis of autism based on PET findings

    Grant number:19H03581  2019.4 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Matsuzaki Hideo

      More details

    Grant amount:\17420000 ( Direct Cost: \13400000 、 Indirect Cost:\4020000 )

    We previously identified N-ethylmaleimide-sensitive factor (NSF) as a new serotonin transporter (SERT)-binding protein and described its importance in SERT membrane trafficking. In this study, we generated Nsf+/- mice and investigated their phenotypes in vivo. Nsf+/- mice exhibited abnormalities in sociability, communication, repetitiveness, and anxiety. Additionally, Nsf loss led to a decrease in membrane SERT expression in the raphe and accumulation of glutamate AMPA receptors at the synaptic membrane surface in the hippocampal CA1 region. We found that postsynaptic density and long-term depression were impaired in the hippocampal CA1 region of Nsf+/- mice. Taken together, these findings demonstrate that NSF plays a role in synaptic plasticity and glutamatergic and serotonergic systems, suggesting a possible mechanism by which the gene is linked to the pathophysiology of autistic behaviors. Intervention trials were also examined, but no significant effect was observed.

    researchmap

  • AMPA受容体シナプス移行促進薬の開発

    2019.4 - 2022.3

    富士フィルム株式会社 

    高橋 琢哉

      More details

    Authorship:Principal investigator 

    researchmap

  • リハビリテーション促進薬開発のためのAMPA受容体PETイメージング研究

    2018.9 - 2023.3

    公益財団法人 武田科学振興財団 

    高橋琢哉

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 放射線リガンド[11C]K-2を用いたてんかん患者におけるAMPA受容体発現量測定を目的とした疫学的臨床試験

    2018.2 - 2021.9

    エーザイ株式会社 

    高橋琢哉

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • (放射性標識)新規AMPA受容体PETイメージング製剤によるてんかん焦点同定の補助診断薬としての臨床開発

    2017.4 - 2020.3

    日本医療研究開発機構  橋渡し研究加速ネットワークプロジェクト 

      More details

    Authorship:Principal investigator 

    researchmap

  • AMPA受容体PETプローブを用いた精神神経疾患横断的研究

    2016.5 - 2021.3

    日本医療研究開発機構  脳科学研究戦略推進プログラム 

    高橋琢哉

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 新規AMPA受容体標識PET薬剤によるてんかん焦点同定の補助診断薬としての臨床開発

    2016.4 - 2017.3

    日本医療研究開発機構  橋渡し研究加速ネットワークプログラム 

    高橋琢哉

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 新規AMPA受容体標識 PET薬剤によるてんかん焦点同定の補助診断薬としての開発

    2016.4 - 2017.3

    日本医療研究開発機構  橋渡し研究加速ネットワークプログラム 

      More details

    Grant type:Competitive

    researchmap

  • シナプス機能分子を認識するPETプローブの開発

    2014.12 - 2019.3

    日本医療研究開発機構  革新的技術による脳機能ネットワークの全容解明プロジェクト 

      More details

    Grant type:Competitive

    researchmap

  • Analysis of neural circuit formation in the neocortex of socially isolated animals

    Grant number:26290025  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    TAKAHASHI Takuya

      More details

    Grant amount:\16770000 ( Direct Cost: \12900000 、 Indirect Cost:\3870000 )

    Social maltreatment early in life can lead to the development of impaired interpersonal relationships and profound social disorders. However, the underlying cellular and molecular mechanisms involved are largely unknown. Here, we found that isolation of neonatal rats induced social dominance over non-isolated control rats from the same litter in juveniles that was glucocorticoid-dependent. Furthermore, neonatal isolation inactivated the actin-depolymerizing factor (ADF)/cofilin in the juvenile medial prefrontal cortex (mPFC). Isolation-induced inactivation of ADF/cofilin resulted in the decrease of glutamate synaptic AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor (AMPAR) contents by the increase of stable actin fractions at dendritic spines in the juvenile mPFC. Thus, neonatal isolation affects spines in the mPFC by reducing actin dynamics, leading to abnormal social behavior later in life.

    researchmap

  • 新規イメージング技術による疾患モデルマウスの解析

    Grant number:26111719  2014.4 - 2016.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    高橋 琢哉

      More details

    Grant amount:\9360000 ( Direct Cost: \7200000 、 Indirect Cost:\2160000 )

    動物が新しいことを経験し学習や適応をする際に、脳に変化が起きる。この変化のことを可塑性と呼ぶ。グルタミン酸シナプスは脳内シナプスの約9割を占めており、精神神経活動において中心的な役割を果たしている。グルタミン酸受容体の中ではAMPA型受容体とNMDA型受容体が主に研究が進んでいる。グルタミン酸受容体の一つであるAMPA受容体はグルタミン酸シナプスの機能を中心的に担っており、従って精神神経機能発現の主役とも言える分子である。
    虐待のひとつである養育放棄(ネグレクト)は全虐待の約40%を占めると言われている。虐待を受けた子どもはその後重篤な精神疾患に罹患することが多い。ネグレクトにおいては、子供は母親や他の子供との接触が著しく減少し、「社会的隔離」状態に陥ることが多い。社会的隔離はシナプスの成熟にどのような影響をもたらすのであろうか?筆者らは生後まもなくのラットに社会的隔離(1日6時間 生後4日から7日)を施し、生後12日から14日の間におけるAMPA受容体のシナプスへの移行(バレル皮質の第IV層からII/III層錐体細胞にかけて形成されるシナプス)を調べた。その結果、社会的隔離によりバレル皮質におけるひげ入力依存的なAMPA受容体のシナプス移行が阻害されることを見出した。
    このような精神疾患のヒトにおける分子レベルでの解析を進めるため、申請者らはシナプス機能分子のヒトにおけるイメージング技術を開発することを目標としている。シナプス機能分子へ結合する候補化合物のスクリーニングにより特定した化合物を用いてPET Probeを作製中である。すでに有望な化合物は見出しており、今後そのvalidationを行っていく

    researchmap

  • 記憶ダイナミクスの時空間的解析

    Grant number:26115519  2014.4 - 2016.3

    日本学術振興会  科学研究費助成事業 新学術領域研究(研究領域提案型)  新学術領域研究(研究領域提案型)

    高橋 琢哉

      More details

    Grant amount:\9360000 ( Direct Cost: \7200000 、 Indirect Cost:\2160000 )

    動物が新しいことを経験し学習や適応をする際に、脳に変化が起きる。この変化のことを可塑性と呼ぶ。グルタミン酸シナプスは脳内シナプスの約9割を占めており、精神神経活動において中心的な役割を果たしている。グルタミン酸受容体の中ではAMPA型受容体とNMDA型受容体が主に研究が進んでいる。グルタミン酸受容体の一つであるAMPA受容体はグルタミン酸シナプスの機能を中心的に担っており、従って精神神経機能発現の主役とも言える分子である。AMPA受容体にはGluA1-GluA4の4つのサブタイプが存在し、この中の組み合わせで4量体を形成している。申請者らは様々な行動/環境における経験依存的AMPA受容体シナプス移行について研究を展開してきた。
    げっ歯類における海馬は非常によく研究されている記憶の中枢である。海馬学習におけるAMPA受容体シナプス移行の関与を検証するために申請者らは海馬依存的文脈恐怖学習であるinhibitory avoidance task (IA task)を使用した。暗い部屋と明るい部屋を隣接させ、ネズミが自由に行き来できるようにする。通常ネズミは暗い部屋を好むため、暗い部屋に入ろうとするが、暗い部屋に入った瞬間に電気ショックを与えると、暗い部屋に入らず明るい部屋に留まる。明るい部屋に留まっている時間が長いということが学習の成立を意味する。筆者らはIA学習成立により海馬CA3-CA1シナプスにおいてAMPA受容体がシナプス後膜へ移行すること、AMPA受容体のシナプスへの移行が記憶成立に必要であることを示した。
    本研究ではシナプス機能分子をヒトでイメージングする方法の開発を目指している。シナプス機能分子へ結合する候補化合物のスクリーニングに上述のIA taskを用いた。このスクリーニングにより特定した化合物を用いてPET Probeを作製中である。すでに有望な化合物は見出しており、今後そのvalidationを行っていく。

    researchmap

  • General anesthesia impairs learning via the saturation of synaptic plasticity.

    Grant number:24592308  2013.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    INAGAWA GAKU, GOTO Takahisa, UCHIMOTO Kazuhiro, TAKAHASI Takuya, MIYAZAKI Tomoyuki, TOMINAGA Yosuke, ASAKURA Ayako, YUBA Yuki, YONEZAKI Kumiko, ADACHI Akiko

      More details

    Grant amount:\5330000 ( Direct Cost: \4100000 、 Indirect Cost:\1230000 )

    General anesthesia induces long-lasting cognitive and learning deficits. However, the underlying mechanism remains unknown. The GluA1 subunit of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a key molecule for learning and synaptic plasticity, which requires trafficking of GluA1-containing AMPARs into the synapse.
    Seven days after exposure to 1.8% isoflurane for 2 h (Iso1.8), the inhibitory avoidance learning (P = 0.002) and long-term potentiation (P < 0.001) were impaired, however, propofol-administrationed model was not impaired (P = 0.14). Iso1.8 also temporarily increased GluA1 in the synaptoneurosomes (P = 0.012) and reduced the GluA1 ubiquitination, a main degradation pathway of GluA1 (P = 0.014).
    Isoflurane impairs hippocampal learning and modulates synaptic plasticity in the postanesthetic period, in contrast to propofol administration. Increased GluA1 may reduce synaptic capacity for additional GluA1-containing AMPARs trafficking.

    researchmap

  • 社会的行動の基盤となる脳機能の計測・支援のための先端的研究開発(発育期社会的隔離ストレスに関連した機能分子スクリーニング系の開発)

    2009.8 - 2014.3

    文部科学省  脳科学研究戦略推進プログラム 課題D 

    高橋 琢哉

      More details

  • 翻訳後修飾プロテオミクス医療研究拠点の形成

    2008 - 2018.3

    文部科学省  イノベーションシステム整備事業 先端融合領域イノベーション創出拠点形成プログラム 

      More details

    Grant type:Competitive

    researchmap

  • The effect of social isolation on the circuit formation in the brain

    Grant number:20300131  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    TAKAHASHI Takuya, HUNABASHI Toshiya, MITSUSHIMA Dai, TAKASE Kenkichi

      More details

    Grant type:Competitive

    Grant amount:\20020000 ( Direct Cost: \15400000 、 Indirect Cost:\4620000 )

    Stressful events during early childhood can have a profound lifelong influence on emotional and cognitive behaviors. However, the mechanisms by which stress affects neonatal brain circuit formation are poorly understood. In this program, we analyzed the effect of neonatal social isolation on the brain circuit formation at the molecular level. We found that neonatal social isolation disrupts experience-dependent synaptic AMPA receptors delivery in the barrel cortex of male rats but not female rats.

    researchmap

  • Identification of novel DOPA ligands and electrophysiological analysis of DOPA-induced response

    Grant number:20300132  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    GOSHIMA Yoshio, TAKAHASHI Takuya, YAGAMI Tatsuro, KAJIWARA Yasuhiro, YURA Kei

      More details

    Grant amount:\19630000 ( Direct Cost: \15100000 、 Indirect Cost:\4530000 )

    DOPA is a novel neurotransmitter candidate in the central nervous system. In an attempt to identify a specific receptor(s) for DOPA, we have searched for selective and stable DOPA ligands. We found a positive fraction in L-threo-dihydroxyphenyserine-containing solution to induce depressor and bradycardic response when microinjected into the nucleus tractus solitarii (NTS) of anesthetized rats. In multiple electrode array system, we also found biphasic response to DOPA in NTS area of rat brain stem slices. While conducting this project, we newly identified a receptor candidate for DOPA.

    researchmap

  • 精神疾患モデル動物におけるAMPA受容体シナプス移行の解析

    2007.10 - 2012.3

    科学技術振興機構(CREST)  戦略的創造研究推進事業 

    高橋 琢哉

      More details

  • 幼児期の社会的隔離が偏桃体における神経回路形成に及ぼす影響

    2007.7 - 2012.9

    武田科学振興財団  特定研究助成[II] 

    高橋 琢哉

      More details

  • 生後初期における社会的隔離が生後後期の経験依存的AMPA受容体のシナプスへの移行に及ぼす影響とその分子機構の解明

    Grant number:18800037  2006 - 2007

    日本学術振興会  科学研究費助成事業 若手研究(スタートアップ)  若手研究(スタートアップ)

    高橋 琢哉

      More details

    Grant type:Competitive

    Grant amount:\2800000 ( Direct Cost: \2800000 )

    本研究は社会的隔離が経験依存的AMPA受容体シナプス移行に及ぼす影響を調べるというものであり、本研究費を用いて以下の事が明らかになった。
    1)経験依存的AMPA受容体シナプス移行が社会的隔離によって阻害される。
    2)社会的隔離による経験依存的AMPA受容体シナプス移行阻害がストレスホルモン受容体のアンタゴニストによって阻害される。
    3)ストレスホルモン受容体のアゴニストの投与によってAMPA受容体シナプス移行阻害が観察される。
    4)社会的隔離を施したラットにおいてはひげーバレルのマップの乱れが観察される。
    5)社会的隔離を施したラットにおいてひげーバレルのマップ依存的な行動に異常が見られる。
    これらの成果により、ストレスがシナプスの成熟に及ぼす影響の分子メカニズムの一端が明らかになった。今後はそのシグナルメカニズムにさらに踏み込んで解析を進めていく。本研究はトラウマの分子細胞メカニズム解明につながる非常に重要なものである。

    researchmap

  • Intruderによるストレスが経験依存的なAMPA受容体のシナプスへの移行に及ぼす影響

    2006

    公益財団法人住友財団  基礎科学研究助成 

    高橋 琢哉

      More details

    Authorship:Principal investigator 

    researchmap

  • 社会的隔離が経験依存的なAMPA受容体のシナプスへの移行に及ぼす影響とその性差

    2006

    公益財団法人かなえ医薬振興財団  研究助成金 

    高橋 琢哉

      More details

    Authorship:Principal investigator 

    researchmap

  • 過食の神経生物学

    2006

    公益財団法人上原記念生命科学財団  研究助成金 

    高橋 琢哉

      More details

    Authorship:Principal investigator 

    researchmap

  • 海馬依存的学習の分子メカニズムの解明:脳機能障害などにおける学習機能改善を目指して

    2006

    公益財団法人第一三共生命科学研究振興財団  研究助成 

    高橋 琢哉

      More details

    Authorship:Principal investigator 

    researchmap

  • アミロイド前駆体蛋白(APP)のシナプス機能の解析

    2006

    公益財団法人ライフサイエンス振興財団  研究助成金 

    高橋 琢哉

      More details

    Authorship:Principal investigator 

    researchmap

▼display all